# EDGAR Filing Document

**Accession Number:** 0000732026
**File Stem:** 0001851734-23-000045
**Filing Date:** 2023-2
**Character Count:** 158456
**Document Hash:** aa3919e5f2d7b20b092687e461a4eb79
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001851734-23-000045.hdr.sgml**: 20230210

**ACCESSION NUMBER**: 0001851734-23-000045

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 107

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230210

**DATE AS OF CHANGE**: 20230210

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TRIO-TECH INTERNATIONAL
- **CENTRAL INDEX KEY:** 0000732026
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIAL INDUSTRY MACHINERY, NEC [3559]
- **IRS NUMBER:** 952086631
- **STATE OF INCORPORATION:** CA
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14523
- **FILM NUMBER:** 23609553

**BUSINESS ADDRESS:**
- **STREET 1:** 16139 WYANDOTTE ST.
- **CITY:** VAN NUYS
- **STATE:** CA
- **ZIP:** 91406
- **BUSINESS PHONE:** 818-787-7000

**MAIL ADDRESS:**
- **STREET 1:** 16139 WYANDOTTE ST.
- **CITY:** VAN NUYS
- **STATE:** CA
- **ZIP:** 91406

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TRIO TECH INTERNATIONAL
- **DATE OF NAME CHANGE:** 19920703

trt20221231_10q.htm

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended December 31, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from ___ to ___

Commission File Number 1-14523

**TRIO-TECH INTERNATIONAL**

(Exact name of Registrant as specified in its Charter

---

| | |
|:---|:---|
| **California** | **95-2086631** |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification Number) |
| **Block 1008 Toa Payoh North** |  |
| **Unit 03-09 Singapore** | **318996** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's Telephone Number, Including Area Code: **(65) 6265 3300**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
|  |  | Name of each exchange |
| <u>Title of each class</u> | <u>Trading Symbol</u> | <u>On which registered</u> |
| Common Stock, no par value | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TRT | NYSE American |

---

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

---

| | | | |
|:---|:---|:---|:---|
| Large Accelerated Filer | ☐ | Accelerated Filer | ☐ |
| Non-Accelerated Filer  | ☐ | Smaller reporting company  | ☒ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of February 1, 2023, there were 4,076,680 shares of the issuer's Common Stock, no par value, outstanding.

------

**TRIO-TECH INTERNATIONAL**

**INDEX TO CONDENSED CONSOLIDATED FINANCIAL INFORMATION, OTHER INFORMATION AND SIGNATURE**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| **Part I.** | **Financial Information** |  |
| &nbsp;&nbsp;&nbsp; Item 1. | Financial Statements | [1](#part1) |
|  | (a) Condensed Consolidated Balance Sheets as of December 31, 2022 (Unaudited), and June 30, 2022 | [1](#part1) |
|  | (b) Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss) for the Three Months Ended December 31, 2022 (Unaudited), and December 31, 2021 (Unaudited) | [2](#ops) |
|  | (c) Condensed Consolidated Statements of Shareholders' Equity for the Three Months Ended December 31, 2022 (Unaudited), and December 31, 2021 (Unaudited) | [4](#equity) |
|  | (d) Condensed Consolidated Statements of Cash Flows for the Three Months Ended December 31, 2022 (Unaudited), and December 31, 2021 (Unaudited) | [5](#flows) |
|  | (e) Notes to Condensed Consolidated Financial Statements (Unaudited) | [6](#notes) |
| &nbsp;&nbsp;&nbsp; Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | [26](#mda) |
| &nbsp;&nbsp;&nbsp; Item 3. | Quantitative and Qualitative Disclosures about Market Risk | [39](#item3_4) |
| &nbsp;&nbsp;&nbsp; Item 4. | Controls and Procedures | [39](#item3_4) |
| **Part II.** | **Other Information** | [40](#part2) |
| &nbsp;&nbsp;&nbsp; Item 1. | Legal Proceedings | [40](#part2) |
| &nbsp;&nbsp;&nbsp; Item 1A. | Risk Factors | [40](#part2) |
| &nbsp;&nbsp;&nbsp; Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | [40](#part2) |
| &nbsp;&nbsp;&nbsp; Item 3. | Defaults upon Senior Securities | [40](#part2) |
| &nbsp;&nbsp;&nbsp; Item 4. | Mine Safety Disclosures | [40](#part2) |
| &nbsp;&nbsp;&nbsp; Item 5. | Other Information | [40](#part2) |
| &nbsp;&nbsp;&nbsp; Item 6. | Exhibits | [40](#part2) |
| **Signatures** | **Signatures** | [41](#signatures) |

---

------

**<u>FORWARD-LOOKING STATEMENTS</u>**

The discussions of Trio-Tech International's (the "Company") business and activities set forth in this Quarterly Report on Form 10-Q (this "Quarterly Report") and in other past and future reports and announcements by the Company may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and assumptions regarding future activities and results of operations of the Company. In light of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, the following factors, among others, could cause actual results to differ materially from those reflected in any forward-looking statements made by or on behalf of the Company: market acceptance of Company products and services; changing business conditions or technologies and volatility in the semiconductor industry, which could affect demand for the Company's products and services; the impact of competition; problems with technology; product development schedules; delivery schedules; changes in military or commercial testing specifications which could affect the market for the Company's products and services; difficulties in profitably integrating acquired businesses, if any, into the Company; risks associated with conducting business internationally and especially in Asia, including currency fluctuations and devaluation, currency restrictions, local laws and restrictions and possible social, political and economic instability; changes in U.S. and global financial and equity markets, including market disruptions and significant interest rate fluctuations; ongoing public health issues related to the COVID-19 pandemic both nationally and internationally; the trade tension between U.S. and China; inflation; the war in Ukraine; other economic, financial and regulatory factors beyond the Company's control and uncertainties relating to our ability to operate our business in China; uncertainties regarding the enforcement of laws and the fact that rules and regulation in China can change quickly with little advance notice, along with the risk that the Chinese government may intervene or influence our operation at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers could result in a material change in our operations, financial performance and/or the value of our common stock, no par value ("Common Stock") or impair our ability to raise money. Other than statements of historical fact, all statements made in this Quarterly Report are forward-looking, including, but not limited to, statements regarding industry prospects, future results of operations or financial position, and statements of our intent, belief and current expectations about our strategic direction, prospective and future financial results and condition. In some cases, you can identify forward-looking statements by the use of terminology such as "may," "will," "expects," "plans," "anticipates," "estimates," "potential," "believes," "can impact," "continue," or the negative thereof or other comparable terminology. Forward-looking statements involve risks and uncertainties that are inherently difficult to predict, which could cause actual outcomes and results to differ materially from our expectations, forecasts and assumptions.

Unless otherwise required by law, we undertake no obligation to update forward-looking statements to reflect subsequent events, changed circumstances, or the occurrence of unanticipated events. You are cautioned not to place undue reliance on such forward-looking statements.

------

**PART I. FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**TRIO-TECH INTERNATIONAL AND SUBSIDIARIES**

**<u>CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS, EXCEPT NUMBER OF SHARES)</u>**

---

| | | |
|:---|:---|:---|
|  | December 31,<br> 2022 | June 30,<br> 2022 |
|  | (Unaudited) |  |
| **ASSETS** |  |  |
| CURRENT ASSETS: |  |  |
| Cash and cash equivalents | $6379 | $7698 |
| Short-term deposits | 4995 | 5420 |
| Trade accounts receivable, less allowance for doubtful accounts of $220 and $243, respectively | 13332 | 11592 |
| Other receivables | 728 | 998 |
| Inventories, less provision for obsolete inventories of $649 and $674, respectively | 3219 | 2258 |
| Prepaid expenses and other current assets | 610 | 1215 |
| &nbsp;&nbsp;&nbsp;Financed sales receivable | 21 | 21 |
| &nbsp;&nbsp;&nbsp;Restricted term deposit | 747 |  |
| **Total current assets** | 30031 | 29202 |
| NON-CURRENT ASSETS: |  |  |
| Deferred tax assets | 93 | 169 |
| Investment properties, net | 533 | 585 |
| Property, plant and equipment, net | 11070 | 8481 |
| Operating lease right-of-use assets | 2580 | 3152 |
| Other assets | 141 | 137 |
| Financed sales receivable | 6 | 17 |
| Restricted term deposits | 1742 | 1678 |
| **Total non-current assets** | 16165 | 14219 |
| **TOTAL ASSETS** | $46196 | $43421 |
| **LIABILITIES** |  |  |
| CURRENT LIABILITIES: |  |  |
| Lines of credit | $- | $929 |
| Accounts payable | 3067 | 2401 |
| Accrued expenses | 6807 | 6004 |
| Income taxes payable | 461 | 787 |
| Current portion of bank loans payable | 511 | 472 |
| Current portion of finance leases | 101 | 118 |
| Current portion of operating leases | 1140 | 1218 |
| **Total current liabilities** | 12087 | 11929 |
| NON-CURRENT LIABILITIES: |  |  |
| Bank loans payable, net of current portion | 1185 | 1272 |
| Finance leases, net of current portion | 69 | 119 |
| Operating leases, net of current portion | 1440 | 1934 |
| Income taxes payable, net of current portion | 255 | 137 |
| Deferred tax liabilities | 15 |  |
| Other non-current liabilities | 1172 | 28 |
| **Total non-current liabilities** | 4136 | 3490 |
| **TOTAL LIABILITIES** | $16223 | $15419 |
| **EQUITY** |  |  |
| TRIO-TECH INTERNATIONAL'S SHAREHOLDERS' EQUITY: |  |  |
| Common stock, no par value, 15,000,000 shares authorized; 4,076,680 and 4,071,680 shares issued outstanding as at December 31 and June 30, 2022, respectively | $12769 | 12750 |
| Paid-in capital | 4762 | 4708 |
| Accumulated retained earnings | 10608 | 9219 |
| Accumulated other comprehensive income-translation adjustments | 1494 | 1197 |
| Total Trio-Tech International shareholders' equity | 29633 | 27874 |
| Non-controlling interest | 340 | 128 |
| **TOTAL EQUITY** | $29973 | $28002 |
| **TOTAL LIABILITIES AND EQUITY** | $46196 | $43421 |

---

See notes to condensed consolidated financial statements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -1-

------

**TRIO-TECH INTERNATIONAL AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS)**

**UNAUDITED (IN THOUSANDS, EXCEPT EARNINGS PER SHARE)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
|  | Dec. 31, | Dec. 31, | Dec. 31, | Dec. 31, |
|  | 2022 | 2021 | 2022 | 2021 |
| **Revenue** |  |  |  |  |
| Manufacturing | $5044 | $3528 | $8629 | $7090 |
| Testing services | 5648 | 4966 | 12012 | 9566 |
| Distribution | 1694 | 2420 | 3676 | 4418 |
| Real estate | 4 | 8 | 12 | 19 |
|  | **12390** | 10922 | **24329** | 21093 |
| **Cost of Sales** |  |  |  |  |
| Cost of manufactured products sold | 3849 | 2874 | 6374 | 5308 |
| Cost of testing services rendered | 3747 | 3089 | 7873 | 5972 |
| Cost of distribution | 1441 | 2050 | 3089 | 3706 |
| Cost of real estate | 18 | 19 | 36 | 38 |
|  | **9055** | 8032 | **17372** | 15024 |
| **Gross Margin** | **3335** | **2890** | **6957** | **6069** |
| **Operating Expenses:** |  |  |  |  |
| General and administrative | 1919 | 1947 | 4224 | 3927 |
| Selling | 193 | 156 | 366 | 303 |
| Research and development | 151 | 131 | 224 | 213 |
| Loss on disposal of property, plant and equipment | 3 |  | 7 |  |
| **Total operating expenses** | 2266 | 2234 | 4821 | 4443 |
| **Income from Operations** | **1069** | **656** | **2136** | **1626** |
| **Other (Expenses) /Income** |  |  |  |  |
| Interest expenses | (10) | (28) | (54) | (56) |
| Other income, net | (243) | 381 | (64) | 542 |
| **Total other (expenses) / income**  | (253) | 353 | (118) | 486 |
| **Income from Continuing Operations before Income Taxes** | 816 | 1009 | 2018 | 2112 |
| **Income Tax Expenses** | (241) | (153) | (466) | (333) |
| **Income from Continuing Operations before Non-controlling Interest, Net of Tax** | 575 | 856 | 1552 | 1779 |
| **Discontinued Operations**  |  |  |  |  |
| (Loss) / Income from discontinued operations, net of tax | (10) |  | (9) | 5 |
| **NET INCOME** | 565 | 856 | 1543 | 1784 |
| Less: net income attributable to non-controlling interest | 58 | 1 | 154 | 12 |
| **Net Income Attributable to Trio-Tech International Common Shareholders** | $507 | $855 | $1389 | $1772 |
| **Amounts Attributable to Trio-Tech International Common Shareholders:** |  |  |  |  |
| Income from continuing operations, net of tax | 512 | 856 | 1394 | 1770 |
| (Loss) / Income from discontinued operations, net of tax | (5) | (1) | (5) | 2 |
| **Net Income Attributable to Trio-Tech International Common Shareholders** | $507 | $855 | $1389 | $1772 |
| **Basic Earnings per Share:** |  |  |  |  |
| Basic earnings per share from continuing operations attributable to Trio-Tech International | $0.12 | $0.22 | $0.34 | $0.46 |
| Basic earnings per share from discontinued operations attributable to Trio-Tech International | $- | $- | $- | $- |
| **Basic Earnings per Share from Net Income Attributable to Trio-Tech International** | $0.12 | $0.22 | $0.34 | $0.46 |
| **Diluted Earnings per Share:** |  |  |  |  |
| Diluted earnings per share from continuing operations attributable to Trio-Tech International | $0.12 | $0.20 | $0.33 | $0.43 |
| Diluted earnings per share from discontinued operations attributable to Trio-Tech International | $- | $- | $- | $- |
| **Diluted Earnings per Share from Net Income Attributable to Trio-Tech International** | $0.12 | $0.20 | $0.33 | $0.43 |
| **Weighted average number of common shares outstanding** |  |  |  |  |
| Basic | 4074 | 3923 | 4074 | 3923 |
| Dilutive effect of stock options | 88 | 319 | 86 | 206 |
| **Number of shares used to compute earnings per share diluted** | 4162 | 4242 | 4160 | 4129 |

---

See notes to condensed consolidated financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -2-

------

**TRIO-TECH INTERNATIONAL AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) / INCOME** 

**UNAUDITED (IN THOUSANDS)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
|  | Dec. 31, | Dec. 31, | Dec. 31, | Dec. 31, |
|  | 2022 | 2021 | 2022 | 2021 |
| **Comprehensive Income Attributable to Trio-Tech International Common Shareholders:** |  |  |  |  |
| Net income | $565 | $856 | $1543 | $1784 |
| Foreign currency translation, net of tax | 1568 | 251 | 355 | (38) |
| **Comprehensive Income** | 2133 | 1107 | 1898 | 1746 |
| Less: comprehensive income attributable to non- controlling interest | 133 | 2 | 212 | 6 |
| **Comprehensive Income Attributable to Trio-Tech International Common Shareholders** | $**2000** | $**1105** | $**1686** | $**1740** |

---

See notes to condensed consolidated financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -3-

------

**TRIO-TECH INTERNATIONAL AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**

**UNAUDITED (IN THOUSANDS)**

**<u>Six months ended December 31, 2022</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | **Paid-in** | **Accumulated Retained** | **Accumulated Other**<br> **Comprehensive** | **Non- controlling** |  |
|  | **Shares** | **Amount** | **Capital** | **Earnings** | **Income** | **Interest** | **Total** |
|  |  | $ | $ | $ | $ | $ | $ |
| Balance at June 30, 2022 | 4072 | 12750 | 4708 | 9219 | 1197 | 128 | 28002 |
| Stock option expenses | *-* |  | 54 |  |  |  | 54 |
| Net income | *-* |  |  | 1389 |  | 154 | 1543 |
| Exercise of stock option | 5 | 19 |  |  |  |  | 19 |
| Translation adjustment | *-* |  |  |  | 297 | 58 | 355 |
| Balance at Dec. 31, 2022 | 4077 | 12769 | 4762 | 10608 | 1494 | 340 | 29973 |

---

**<u>Six months ended December 31, 2021</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | **Paid-in** | **Accumulated Retained** | **Accumulated Other**<br> **Comprehensive** | **Non- controlling** |  |
|  | **Shares** | **Amount** | **Capital** | **Earnings** | **Income** | **Interest** | **Total** |
|  |  |  | $— | $— | $— |  |  |
| Balance at June 30, 2021 | 3913 |  |  |  |  |  |  |
| Stock option expenses | *-* |  |  |  |  |  |  |
| Net income | *-* |  |  |  |  |  |  |
| Dividend declared by subsidiary | *-*) |  |  |  |  |  |  |
| Exercise of stock option | 41 |  |  |  |  |  |  |
| Translation adjustment | *-*) |  |  |  |  |  |  |
| Balance at Dec. 31, 2021 | 3954 |  |  |  |  |  |  |

---

See notes to condensed consolidated financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -4-

------

**TRIO-TECH INTERNATIONAL AND SUBSIDIARIES** 

**<u>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</u> <u>(IN THOUSANDS)</u>**

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31, | Dec. 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| **Cash Flow from Operating Activities** |  |  |
| Net income | $1543 | $1784 |
| Adjustments to reconcile net income/(loss) to net cash flow provided by operating activities |  |  |
| Depreciation and amortization | 2143 | 1502 |
| (Reversal) / Addition of provision for obsolete inventories | (41) | 26 |
| Stock option expense | 54 | 22 |
| Bad debt provision | (17) | (62) |
| Accrued interest expense, net accrued interest income | (8) | 51 |
| Payment of interest portion of finance lease | (6) | (13) |
| Loss on sale of property, plant and equipment - continuing operations | 8 |  |
| Warranty recovery, net | 2 |  |
| Deferred tax expense | 94 | 62 |
| Changes in operating assets and liabilities, net of acquisition effects |  |  |
| Trade accounts receivable | (1507) | (1501) |
| Other receivables | 60 | (1725) |
| Other assets | (4) | 125 |
| Inventories | (821) | (525) |
| Prepaid expenses and other current assets | 588 | (79) |
| Accounts payable and accrued expenses | 1338 | 1638 |
| Income taxes payable | (197) | 2 |
| Other non-current liabilities | 1144 |  |
| Operating lease liabilities | (594) | (470) |
| **Net Cash Provided by Operating Activities** | $**3779** | $**837** |
| **Cash Flow from Investing Activities** |  |  |
| Withdrawal from unrestricted term deposits, net | 2841 | 1957 |
| Investment in unrestricted term deposits, net | (2275) | (320) |
| Additions to property, plant and equipment | (3994) | (795) |
| **Net Cash (Used in) / Provided by Investing Activities** | **(3428)** | **842** |
| **Cash Flow from Financing Activities** |  |  |
| Payment on lines of credit | (1402) | (546) |
| Payment of bank loans | (234) | (216) |
| Payment of finance leases | (67) | (106) |
| Dividends paid to non-controlling interest |  | (119) |
| Proceeds from exercising stock options | 19 | 118 |
| Proceeds from lines of credit | 476 | 942 |
| Proceeds from bank loans | 176 |  |
| **Net Cash (Used in) / Provided by Financing Activities** | **(1032)** | **73** |
| **Effect of Changes in Exchange Rate** | 173 | (68) |
| **Net (Decrease) / Increase in Cash, Cash Equivalents, and Restricted Cash** | (508) | 1684 |
| **Cash, Cash Equivalents, and Restricted Cash at Beginning of Period** | 9376 | 7577 |
| **Cash, Cash Equivalents, and Restricted Cash at End of Period** | $**8868** | $**9261** |
| **Supplementary Information of Cash Flows** |  |  |
| Cash paid during the period for: |  |  |
| Interest | $53 | $56 |
| Income taxes | $346 | $281 |
| **Reconciliation of Cash, Cash Equivalents, and Restricted Cash** |  |  |
| **Cash** | 6379 | 7526 |
| Restricted Term-Deposits in Current Assets | 747 |  |
| **Restricted Term-Deposits in Non-Current Assets**  | 1742 | 1735 |
| **Total Cash, Cash Equivalents, and Restricted Cash Shown in Statements of Cash Flows** | $8868 | $9261 |

---

See notes to condensed consolidated financial statements.

Restricted deposits represent the amount of cash pledged to secure loans payable or trade financing granted by financial institutions, serve as collateral for public utility agreements such as electricity and water, and performance bonds related to customs duty payable. Restricted deposits are classified as current and non-current depending on whether they relate to long term or short-term obligations. Restricted deposit of $747 is classified as current assets as it relates to short-term trade financing. On the other hand, restricted deposits of $1,742 is classified as non-current assets as they relate to long-term obligations and will become unrestricted only upon discharge of the obligations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -5-

------

**TRIO-TECH INTERNATIONAL AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(IN THOUSANDS, EXCEPT EARNINGS PER SHARE AND NUMBER OF SHARES)**

***1.* ORGANIZATION AND BASIS OF PRESENTATION**

Trio-Tech International (the "Company", or "TTI") was incorporated in fiscal year ended *June 30, 1958* under the laws of the State of California. TTI provides *third*-party semiconductor testing and burn-in services primarily through its laboratories in Southeast Asia. In addition, TTI operates testing facilities in the United States ("U.S."). The Company also designs, develops, manufactures and markets a broad range of equipment and systems used in the manufacturing and testing of semiconductor devices and electronic components. In the *second* quarter of the fiscal year ended *June 30, 2023 (*"Fiscal *2023"*), TTI conducted business in *four* business segments: Manufacturing, Testing Services, Distribution and Real Estate. TTI has subsidiaries in the U.S., Singapore, Malaysia, Thailand, Indonesia, Ireland and China as follows:

---

| | | |
|:---|:---|:---|
|  | <u>Ownership</u> | <u>Location</u> |
| Express Test Corporation (Dormant) | 100% | *Van Nuys, California* |
| Trio-Tech Reliability Services (Dormant) | 100% | *Van Nuys, California* |
| KTS Incorporated, dba Universal Systems (Dormant) | 100% | *Van Nuys, California* |
| European Electronic Test Centre (Dormant) | 100% | *Dublin, Ireland* |
| Trio-Tech International Pte. Ltd. | 100% | *Singapore* |
| Universal (Far East) Pte. Ltd.\* | 100% | *Singapore* |
| Trio-Tech International (Thailand) Co. Ltd. \* | 100% | *Bangkok, Thailand* |
| Trio-Tech (Bangkok) Co. Ltd. \* | 100% | *Bangkok, Thailand* |
| Trio-Tech (Malaysia) Sdn. Bhd.<br> (55% owned by Trio-Tech International Pte. Ltd.) | 55% | *Penang and Selangor, Malaysia* |
| Trio-Tech (Kuala Lumpur) Sdn. Bhd. | 55% | *Selangor, Malaysia* |
| (100% owned by Trio-Tech Malaysia Sdn. Bhd.) |  |  |
| Prestal Enterprise Sdn. Bhd. | 76% | *Selangor, Malaysia* |
| (76% owned by Trio-Tech International Pte. Ltd.) |  |  |
| Trio-Tech (SIP) Co., Ltd. \* | 100% | *Suzhou, China* |
| Trio-Tech (Chongqing) Co. Ltd. \* | 100% | *Chongqing, China* |
| SHI International Pte. Ltd. (Dormant)<br> (55% owned by Trio-Tech International Pte. Ltd) | 55% | *Singapore* |
| PT SHI Indonesia (Dormant)<br> (100% owned by SHI International Pte. Ltd.) | 52% | *Batam, Indonesia* |
| Trio-Tech (Tianjin) Co., Ltd. \* | 100% | *Tianjin, China* |
| Trio-Tech (Jiangsu) Co., Ltd.<br> (51% owned by Trio-Tech (SIP) Co., Ltd.) | 51% | *Suzhou, China* |

---

\* 100% owned by Trio-Tech International Pte. Ltd.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles ("GAAP") for interim financial information and with the instructions to Form *10*-Q and Article *10* of Regulation S-*X.* All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements are presented in U.S. dollars unless otherwise stated. The accompanying condensed consolidated financial statements do *not* include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report for the fiscal year ended *June 30, 2022 (*"Fiscal *2022"*). The Company's operating results are presented based on the translation of foreign currencies using the respective quarter's average exchange rate.

The results of operations for the *six* months ended *December 31, 2022* are *not* necessarily indicative of the results that *may* be expected for any other interim period or for the full year ending *June 30, 2023.*

*Use of Estimates* — The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Among the more significant estimates included in these consolidated financial statements are the estimated allowance for doubtful account receivables, reserve for obsolete inventory, impairments, provision of income tax, stock options and the deferred income tax asset allowance. Actual results could materially differ from those estimates.

*Significant Accounting Policies.* There have been *no* material changes to our significant accounting policies summarized in Note *1* "Basis of Presentation and Summary of Significant Accounting Policies" to our consolidated Financial Statements included in our Annual Report on Form *10*-K for Fiscal *2022.*

 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *6*-

------

***2.* NEW ACCOUNTING PRONOUNCEMENTS**

In *March 2022,* the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") *2022*-*02* updating Accounting Standards Codification ("ASC") Topic *326: Financial Instruments*—*Credit Losses* (Topic *326*): *Troubled Debt Restructurings* ("TDR") *and Vintage Disclosures* ("ASU *2022*-*02"*), which require that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investment in leases within the scope of Subtopic *326*-*20.* The Company has completed its assessment and concluded that ASU *2022*-*02* has *no* significant impact to the Company's consolidated financial statements.

In *November 2021,* FASB issued ASU *2021*-*10* ASC Topic *832: Government Assistance* ("Topic *832"): Disclosures by Business Entities about Government Assistance* ("ASU *2021*-*10"*), which expected to increase transparency in financial reporting by requiring business entities to disclose information about certain types of government assistance received. ASU *2021*-*10* is effective for financial statements issued for annual periods beginning after *December 15, 2021* for all entities except *not*-for-profit entities and employee benefit plans within the scope of Topics *960, 962,* and *965* on plan accounting. The Company has completed its assessment and concluded that ASU *2021*-*10* is applicable to the Company as the Company received government grants. The Company will make the necessary disclosures in the financial statements for Fiscal *2023.*

In *June 2016,* FASB issued ASU *2016*-*13* ASC Topic *326, Financial Instruments* — *Credit Losses* ("Topic *326"*) ("ASU *2016*-*13"*) for the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Topic *326* is effective for the Company for annual periods beginning after *December 15, 2022.* The Company has completed its assessment and concluded that ASU *2016*-*03* has *no* significant impact to the Company's consolidated financial statements.

Other new pronouncements issued but *not* yet effective until after *December 31, 2022,* are *not* expected to have a significant effect on the Company's consolidated financial position or results of operations.

***3.* TERM DEPOSITS**

---

| | | |
|:---|:---|:---|
|  | Dec. 31, | June 30, |
|  | 2022 | 2022 |
|  | (Unaudited) |  |
| Short-term deposits | $4756 | $5619 |
| Currency translation effect on short-term deposits | 239 | (199) |
| Total short-term deposits | 4995 | 5420 |
| Restricted term deposits- Current | 711 |  |
| Currency translation effect on restricted term deposits | 36 |  |
| Total restricted term deposits-Current | 747 |  |
| Restricted term deposits-Non-Current | 1634 | 1746 |
| Currency translation effect on restricted term deposits | 108 | (68) |
| Total restricted term deposits-Non-Current | 1742 | 1678 |
| Total term deposits | $7484 | $7098 |

---

Restricted deposits represent the amount of cash pledged to secure loans payable or trade financing granted by financial institutions and serve as collateral for public utility agreements such as electricity and water, and performance bonds related to customs duty payable. Restricted deposits are classified as current and non-current depending on whether they relate to long term or short-term obligations. Restricted deposit of $747 is classified as current assets as it relates to short-term trade financing. On the other hand, restricted deposits of $1,742 is classified as non-current assets as they relate to long-term obligations and will become unrestricted only upon discharge of the obligations. Short-term deposits represent bank deposits, which do not qualify as cash equivalents.

***4.* TRADE ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS**

Accounts receivable are customer obligations due under normal trade terms. The Company performs continuing credit evaluations of its customers' financial conditions, and although management generally does *not* require collateral, letters of credit *may* be required from the customers in certain circumstances.

Senior management reviews accounts receivable on a periodic basis to determine if any receivables will potentially be uncollectible. Management includes any accounts receivable balances that are determined to be uncollectible in the allowance for doubtful accounts. After all reasonable attempts to collect a receivable have failed, the receivable is written off against the allowance. Based on the information available, management believed the allowance for doubtful accounts as of *December 31, 2022,* and *June 30, 2022,* was adequate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *7*-

------

The following table represents the changes in the allowance for doubtful accounts:

---

| | | |
|:---|:---|:---|
|  | Dec. 31, | June 30, |
|  | 2022 | 2022 |
|  | (Unaudited) |  |
| Beginning | $243 | $311 |
| Additions charged to expenses |  | 48 |
| Recovered | (17) | (106) |
| Currency translation effect | (6) | (10) |
| Ending | $220 | $243 |

---

***5.* LOANS RECEIVABLE FROM PROPERTY DEVELOPMENT PROJECTS**

The following table presents Trio-Tech (Chongqing) Co. Ltd ("TTCQ")'s loan receivables from property development projects in China as of *December 31, 2022.*

---

| | | | |
|:---|:---|:---|:---|
|  | **Loan Expiry** | **Loan Amount** | **Loan Amount** |
|  | **Date** | **(RMB)** | **(U.S. Dollars)** |
| Short-term loan receivables |  |  |  |
| JiangHuai (Project – Yu Jin Jiang An) | *May 31, 2013* | 2000 | 290 |
| *Less: allowance for doubtful receivables* | *Less: allowance for doubtful receivables* | (2000) | (290) |
| *Net loan receivables from property development projects* | *Net loan receivables from property development projects* |  |  |
| Long-term loan receivables |  |  |  |
| Jun Zhou Zhi Ye | *Oct 31, 2016* | 5000 | 814 |
| *Less: transfer – down-payment for purchase of investment property* | *Less: transfer – down-payment for purchase of investment property* | (5000) | (814) |
| *Net loan receivables from property development projects* | *Net loan receivables from property development projects* |  |  |

---

The short-term loan receivables amounting to renminbi ("RMB") 2,000, or approximately $290 arose due to TTCQ entering into a Memorandum Agreement with JiangHuai Property Development Co. Ltd. ("JiangHuai") to invest in their property development projects (Project - Yu Jin Jiang An) located in Chongqing City, China during year ended *June 30, 2011.* TTCQ did *not* generate other income from JiangHuai for the quarter ended *December 31, 2022* or for Fiscal *2022.* TTCQ is in the legal process of recovering the outstanding amount of approximately $290.

The loan-term loan to RMB 5,000, or approximately $814, arose from TTCQ entering into a Memorandum Agreement with JiaSheng Property Development Co. Ltd. ("JiaSheng") to invest in JiaSheng's projects (Project B-*48* Phase *2*) located in Chongqing City, China during the year ended *June 30, 2011.* The loan receivable was unsecured and repayable at the end of the term. During the year ended *June 30, 2015,* the loan receivable was transferred to down payment for purchase of investment property that is being developed in the Singapore Themed Resort Project (See Note *8*).

***6.* INVENTORIES**

Inventories consisted of the following:

---

| | | |
|:---|:---|:---|
|  | Dec. 31, 2022 | June 30, 2022 |
|  | (Unaudited) |  |
| Raw materials | $1261 | $1764 |
| Work in progress | 1669 | 683 |
| Finished goods | 821 | 238 |
| Less: provision for obsolete inventories | (649) | (674) |
| Currency translation effect | 117 | 247 |
|  | $3219 | $2258 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *8*-

------

The following table represents the changes in provision for obsolete inventories:

---

| | | |
|:---|:---|:---|
|  | Dec. 31, 2022 | June 30, 2022 |
|  | (Unaudited) |  |
| Beginning | $674 | $679 |
| Additions charged to expenses |  | 17 |
| Usage – disposition | (41) | (34) |
| Currency translation effect | 16 | 12 |
| Ending | $649 | $674 |

---

***7.* INVESTMENT PROPERTIES**

The following table presents the Company's investment in properties in China as of *December 31, 2022.* The exchange rate is based on the market rate as of *December 31, 2022.*

---

| | | | |
|:---|:---|:---|:---|
|  | **Investment Date / Reclassification** | **Investment**<br> **Amount** | **Investment Amount** |
|  | **Date** | **(RMB)** | **(U.S. Dollars)** |
| Purchase of rental property – Property I – MaoYe Property | *Jan 04, 2008* | 5554 | 894 |
| *Currency translation* | *Currency translation* |  | (87) |
| Reclassification as "Assets held for sale" | *July 01, 2018* | (5554) | (807) |
| Reclassification from "Assets held for sale" | *Mar 31, 2019* | 2024 | 301 |
|  |  | 2024 | 301 |
| Purchase of rental property – Property II - JiangHuai | *Jan 06, 2010* | 3600 | 580 |
| Purchase of rental property – Property III - FuLi | *Apr 08, 2010* | 4025 | 648 |
| *Currency translation* | *Currency translation* |  | (130) |
| *Gross investment in rental property* | *Gross investment in rental property* | 9649 | 1399 |
| Accumulated depreciation on rental property | *Dec 31, 2022* | (7764) | (1133) |
| Reclassified as "Assets held for sale"- MaoYe Property | *July 01, 2018* | 2822 | 410 |
| Reclassification from "Assets held for sale"- MaoYe Property | *Mar 31, 2019* | (1029) | (143) |
|  |  | (5971) | (866) |
| *Net investment in property – China* | *Net investment in property – China* | **3678** | **533** |

---

The following table presents the Company's investment in properties in China as of *June 30, 2022.* The exchange rate is based on the market rate as of *June 30, 2022.*

---

| | | | |
|:---|:---|:---|:---|
|  | **Investment Date /**<br> **Reclassification** | **Investment Amount** | **Investment Amount** |
|  | **Date** | **(RMB)** | **(U.S. Dollars)** |
| Purchase of rental property – Property I – MaoYe Property | *Jan 04, 2008* | 5554 | 894 |
| *Currency translation* | *Currency translation* |  | (87) |
| Reclassification as "Assets held for sale" | *July 01, 2018* | (5554) | (807) |
| Reclassification from "Assets held for sale" | *Mar 31, 2019* | 2024 | 301 |
|  |  | 2024 | 301 |
| Purchase of rental property – Property II - JiangHuai | *Jan 06, 2010* | 3600 | 580 |
| Purchase of rental property – Property III - FuLi | *Apr 08, 2010* | 4025 | 648 |
| *Currency translation* | *Currency translation* |  | (89) |
| *Gross investment in rental property* | *Gross investment in rental property* | 9649 | 1440 |
| Accumulated depreciation on rental property | *Jun 30, 2022* | (7523) | (1122) |
| Reclassified as "Assets held for sale"- MaoYe Property | *July 01, 2018* | 2822 | 410 |
| Reclassification from "Assets held for sale"- MaoYe Property | *Mar 31, 2019* | (1029) | (143) |
|  |  | (5730) | (855) |
| *Net investment in property – China* | *Net investment in property – China* | **3919** | **585** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *9*-

------

**Rental Property I - MaoYe Property**

In the fiscal year ended *June 30, 2008,* TTCQ purchased an office in Chongqing, China from MaoYe Property Ltd. ("MaoYe") for a total cash purchase price of RMB 5,554, or approximately $894. During the year ended *June 30, 2019,* the Company sold *thirteen* of the *fifteen* units constituting the MaoYe Property. Management has decided *not* to sell the remaining *two* units of MaoYe properties in the near future, due to current conditions of the property market in China. The lease agreement, which was entered into on *February 10, 2022* has been terminated on *October 2022.* A new agreement has been secured and will be effective from *February 1, 2023* for a period of *4* years at a monthly rate of RMB15, or approximately $2, after termination of the previous agreement. Pursuant to the agreement, monthly rental will increase by *5%* each year from *third* year onwards.

Property purchased from MaoYe generated a rental income of $2 and $8 during the *three* and *six* months ended *December 31, 2022,* as compared to $2 and $4 for the same period in Fiscal *2022.*

Depreciation expense for MaoYe was $4 and $8 during the *three* and *six* months ended *December 31, 2022,* as compared to $4 and $8 for the same period in Fiscal *2022.*

**Rental Property II - JiangHuai**

During the year ended *June 30, 2010 (*"Fiscal *2010"*), TTCQ purchased *eight* units of commercial property in Chongqing, China from Chongqing JiangHuai Real Estate Development Co. Ltd. ("JiangHuai") for a total purchase price of RMB 3,600, or approximately $580. As of *December 31, 2022,* TTCQ had *not* received the title deed for properties purchased from JiangHuai. While the above is *not* expected to affect the property's market value, the COVID-*19* pandemic and current economic situation is likely to cause delays in court to consummate the execution of the sale.

Property purchased from JiangHuai did *not* generate any rental income for the *three* and *six* months ended *December 31, 2022* and *2021.*

Depreciation expense for JiangHuai was $7 and $14 for the *three* and *six* months ended *December 31, 2022,* as compared to $7 and $14 for the same period in Fiscal *2022.*

**Rental Property III** – **FuLi**

In Fiscal *2010,* TTCQ entered into a Memorandum Agreement with Chongqing FuLi Real Estate Development Co. Ltd. ("FuLi") to purchase two commercial properties totaling 311.99 square meters ("Office Space") located in Jiang Bei District Chongqing. The total purchase price committed and paid was RMB 4,025, or approximately $648. The development was completed, the property was transferred to TTCQ in *April 2013* and the title deed was received during the *third* quarter of Fiscal *2014.*

As of mid *August 2022,* TTCQ had found a new tenant for *one* of the *two* commercial properties for a period of *1* year at a monthly rate of RMB6, or approximately $1. TTCQ is actively searching for tenants to occupy the other commercial property, which is vacant as of the date of this Report.

Properties purchased from FuLi generated a rental income of $2 and $4 for the *three* and *six* months ended *December 31, 2022,* as compared to $5 and $14 for the same period in Fiscal *2022.*

Depreciation expense for FuLi was $7 and $15 for the *three* and *six* months ended *December 31, 2022,* as compared to $8 and $16 for the same period in Fiscal *2022.*

**Summary**

Total rental income for all investment properties in China was $4 and $12 for the *three* and *six* months ended *December 31, 2022,* as compared to $8 and $19 for the same period in Fiscal *2022.*

Depreciation expenses for all investment properties in China were $18 and $36 for the *three* and *six* months ended *December 31, 2022,* as compared to $19 and $38 for the same period in Fiscal *2022.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *10*-

------

***8.* OTHER ASSETS**

Other assets consisted of the following:

---

| | | |
|:---|:---|:---|
|  | Dec. 31, | June 30, |
|  | 2022 | 2022 |
|  | (Unaudited) |  |
| Down payment for purchase of investment properties \* | $- | $- |
| Deposits for rental and utilities and others | 134 | 142 |
| Currency translation effect | 7 | (5) |
| **Total** | $**141** | $**137** |

---

\*Down payment for purchase of investment properties included:

---

| | | |
|:---|:---|:---|
|  | RMB | U.S. Dollars |
| Original Investment (10% of Junzhou equity) | $10000 | $1606 |
| Less: Management Fee | (5000) | (803) |
| Net Investment | 5000 | 803 |
| Less: Share of Loss on Joint Venture | (137) | (22) |
| **Net Investment as Down Payment (Note \*a)** | **4863** | **781** |
| Loans Receivable | 5000 | 814 |
| Interest Receivable | 1250 | 200 |
| Less: Impairment of Interest | (906) | (150) |
| **Transferred to Down Payment (Note \*b)** | **5344** | **864** |
| **\* Down Payment for Purchase of Investment Properties** | **10207** | **1645** |
| **Less: Effect of foreign currency exchange** | ***-*** | **(65)** |
| **Less: Provision of Impairment loss on other assets** | **(10207)** | **(1580)** |
| **\* Down Payment for Purchase of Investment Properties** | $*-* | $*-* |

---

a) In Fiscal *2011,* the Company signed a Joint Venture agreement (the "Agreement") with Jia Sheng Property Development Co. Ltd. (the "Developer") to form a new company, Junzhou Co. Limited ("Joint Venture" or "Junzhou"), to jointly develop the "Singapore Themed Park" project (the "Project"). The Company paid RMB10,000 for the 10% investment in the Joint Venture. The Developer paid the Company a management fee of RMB 5,000 in cash upon signing of the Agreement, with a remaining fee of RMB 5,000 payable upon fulfilment of certain conditions in accordance with the Agreement. The Company further reduced its investment by RMB 137, or approximately $22, through the losses from operations incurred by the Joint Venture. In Fiscal *2014,* the Company disposed of its entire 10% interest in the Joint Venture but, to date, has *not* received payment in full. The Company recognized a disposal based on the recorded net book value of RMB 5,000, or equivalent to $803, from net considerations paid, in accordance with GAAP under ASC Topic *845* Non-monetary Consideration. It is presented under "Other Assets" as noncurrent assets to defer the recognition of the gain on the disposal of the 10% interest in the Joint Venture investment until such time that the consideration is paid, so the gain can be ascertained.

b) Amounts of RMB 5,000, or approximately $814, as disclosed in Note *5,* plus the interest receivable on long-term loan receivable of RMB 1,250, or approximately $200, and impairment on interest of RMB 906, or approximately $150. The shop lots are to be delivered to TTCQ upon completion of the construction of the shop lots in the Project. The initial targeted date of completion was in the fiscal year ended *June 30, 2017.* However, the progress has been delayed as the developer is currently undergoing asset reorganization process, to re-negotiate with their creditors to complete the project. During the *fourth* quarter of Fiscal *2021,* the Company accrued an impairment charge of $1,580 related to the doubtful recovery of the down payment on property in the Project in Chongging, China. The Company recorded a non-cash impairment charge due to increased uncertainties regarding the project's viability, given the developers weakening financial condition as well as uncertainties arising from the negative real-estate environment in China, implementation of control measures on real-estate lending in China and its relevant government policies, together with effects of the ongoing pandemic. The local court is verifying the documents due to the sizable number of creditors as of *December 31, 2022.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *11*-

------

***9.* LINES OF CREDIT**

Carrying value of the Company's lines of credit approximates its fair value because the interest rates associated with the lines of credit are adjustable in accordance with market situations when the Company borrowed funds with similar terms and remaining maturities.

The Company's credit rating provides it with ready and adequate access to funds in global markets.

As of *December 31, 2022,* the Company had certain lines of credit that are collateralized by restricted deposits.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| Entity with | Type of | Interest | Interest | Interest | Credit | Unused |
| Facility | Facility | Rate | Rate | Rate | Limitation | Credit |
| Trio-Tech International Pte. Ltd., Singapore | Lines of Credit | *Ranging from 1.85%* | *to* | 5.5% | $3957 | $3957 |
| Universal (Far East) Pte. Ltd. | Lines of Credit | *Ranging from 1.85%* | *to* | 5.5% | $1867 | $1841 |
| Trio-Tech Malaysia Sdn. Bhd. | *Revolving credit* | *Cost of Funds Rate +2%* | *Cost of Funds Rate +2%* | *Cost of Funds Rate +2%* | $341 | $341 |

---

As of *June 30, 2022,* the Company had certain lines of credit that are collateralized by restricted deposits.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| Entity with | Type of | Interest | Interest | Interest | Credit | Unused |
| Facility | Facility | Rate | Rate | Rate | Limitation | Credit |
| Trio-Tech International Pte. Ltd., Singapore | Lines of Credit | *Ranging from 1.85%* | *to* | 5.5% | $4090 | $3651 |
| Universal (Far East) Pte. Ltd. | Lines of Credit | *Ranging from 1.85%* | *to* | 5.5% | $1076 | $586 |
| Trio-Tech Malaysia Sdn. Bhd. | *Revolving credit* | *Cost of Funds Rate +2%* | *Cost of Funds Rate +2%* | *Cost of Funds Rate +2%* | $338 | $338 |

---

***10.* ACCRUED EXPENSE**

Accrued expense consisted of the following:

---

| | | |
|:---|:---|:---|
|  | Dec. 31, | June 30, |
|  | 2022 | 2022 |
|  | (Unaudited) |  |
| Payroll and related costs | $1864 | $2158 |
| Commissions | 125 | 116 |
| Legal and audit | 284 | 320 |
| Sales tax | 241 | 531 |
| Utilities | 194 | 273 |
| Warranty | 23 | 16 |
| Accrued purchase of materials and property, plant and equipment | 1679 | 905 |
| Provision for reinstatement | 298 | 308 |
| Contract liabilities | 1282 | 988 |
| Other accrued expense | 692 | 581 |
| Currency translation effect | 125 | (192) |
| **Total** | $**6807** | $**6004** |

---

***11.* WARRANTY ACCRUAL**

The Company provides for the estimated costs that *may* be incurred under its warranty program at the time the sale is recorded. The warranty period of the products manufactured by the Company is generally *one* year or the warranty period agreed upon with the customer. The Company estimates the warranty costs based on the historical rates of warranty returns. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amounts as necessary.

---

| | | |
|:---|:---|:---|
|  | Dec. 31, | June 30, |
|  | 2022 | 2022 |
|  | (Unaudited) |  |
| Beginning | $16 | $14 |
| Additions charged to cost and expense | 25 | 7 |
| Utilisation/Reversal | (17) | (4) |
| Currency translation effect | (1) | (1) |
| **Ending** | $**23** | $**16** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *12*-

------

***12.* BANK LOANS PAYABLE**

Bank loans payable consisted of the following:

---

| | | |
|:---|:---|:---|
|  | Dec. 31, | June 30, |
|  | 2022 | 2022 |
|  | (Unaudited) |  |
| Note payable denominated in the Malaysian Ringgit for expansion plans in Malaysia, maturing in April 2028, bearing interest at the bank's prime rate less 2.00% (4.6% and 3.791% at December 31, 2022 and June 30, 2022) per annum, with monthly payments of principal plus interest through August 2028, collateralized by the acquired building with a carrying value of $2,372 as at December 31, 2022 and June 30, 2022. | $1215 | $1392 |
| Financing arrangement at fixed interest rate 3.2% per annum, with monthly payments of principal plus interest through July 2025. | 109 | 128 |
| Financing arrangement at fixed interest rate 3.0% per annum, with monthly payments of principal plus interest through December 2026. | 204 | 224 |
| Financing arrangement at fixed interest rate 3.0% per annum, with monthly payments of principal plus interest through August 2027. | 168 |  |
| **Total bank loans payable** | $**1696** | $**1744** |
| Current portion of bank loans payable | 506 | 503 |
| Currency translation effect on current portion of bank loans | 5 | (31) |
| **Current portion of bank loans payable** | **511** | **472** |
| Long-term portion of bank loans payable | 1179 | 1357 |
| Currency translation effect on long-term portion of bank loans | 6 | (85) |
| **Long-term portion of bank loans payable** | $**1185** | **1272** |

---

Future minimum payments (excluding interest) as of *December 31, 2022,* were as follows:

---

| | |
|:---|:---|
| Remainder of Fiscal 2023 | $269 |
| 2024 | 513 |
| 2025 | 283 |
| 2026 | 251 |
| 2027 | 216 |
| Thereafter | 164 |
| **Total obligations and commitments** | $**1696** |

---

Future minimum payments (excluding interest) as of *June 30, 2022,* were as follows:

---

| | |
|:---|:---|
| 2023 | $472 |
| 2024 | 481 |
| 2025 | 246 |
| 2026 | 214 |
| 2027 | 190 |
| Thereafter | 141 |
| **Total obligations and commitments** | $**1744** |

---

***13.* COMMITMENTS AND CONTINGENCIES**

Deposits with banks are *not* insured by the local government or agency and are consequently exposed to risk of loss. The Company believes that the probability of bank failure, causing loss to the Company, is remote.

The Company is, from time to time, the subject of litigation claims and assessments arising out of matters occurring in its normal business operations. In the opinion of management, resolution of these matters will *not* have a material adverse effect on the Company's financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *13*-

------

***14.* BUSINESS SEGMENTS**

The Company operated in four segments; the testing service industry (which performs structural and electronic tests of semiconductor devices), the designing and manufacturing of equipment (assembly of equipment that tests the structural integrity of integrated circuits and other products), distribution of various products from other manufacturers in Singapore and Asia and the real estate segment in China.

The cost of equipment, current year investment in new equipment and depreciation expense are allocated into respective segments based on primary purpose for which the equipment was acquired.

All intersegment sales were sales from the manufacturing segment to the testing and distribution segment. Total intersegment sales were $115 and $669 for *three* and *six* months ended *December 31, 2022,* as compared to $232 and $820 for the same period in fiscal *2022.* Corporate assets consisted primarily of cash and prepaid expenses. Corporate expenses consisted primarily of stock option expense, salaries, insurance, professional expenses and directors' fees. Corporate expenses are allocated to the four segments on a predetermined fixed amount calculated based on the annual budgeted sales, except the Malaysia operation, which is calculated based on actual sales. The following segment information table includes segment operating income or loss after including corporate expenses allocated to the segments, which gets eliminated in the consolidation.

The following segment Information is unaudited for the *six* months ended *December 31, 2022,* and *December 31, 2021:*

**Business Segment Information:** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Six Months |  | Operating |  |  |  |
|  | Ended | Net | Income / | Total | Depr. And | Capital |
|  | Dec. 31, | Revenue | (Loss) | Assets | Amort. | Expenditures |
| Manufacturing | *2022* | $8629 | $477 | $15345 | $230 | $15 |
|  | *2021* | $7090 | $252 | $14799 | $208 | $95 |
| Testing Services | *2022* | 12012 | 1129 | 27757 | 1875 | 3967 |
|  | *2021* | 9566 | 1124 | 24546 | 1251 | 699 |
| Distribution | *2022* | 3676 | 482 | 1437 |  |  |
|  | *2021* | 4418 | 531 | 1850 | 2 |  |
| Real Estate | *2022* | 12 | (42) | 1580 | 38 |  |
|  | *2021* | 19 | (51) | 1283 | 41 | 1 |
| Corporate & Unallocated | *2022* |  | 90 | 77 |  | 12 |
|  | *2021* |  | (230) | 74 |  |  |
| Total Company | *2022* | $24329 | $2136 | $46196 | $2143 | $3994 |
|  | *2021* | $21093 | $1626 | $42552 | $1502 | $795 |

---

The following segment Information is unaudited for the *three* months ended *December 31, 2022,* and *December 31, 2021:*

**Business Segment Information:** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Three Months |  | Operating |  |  |  |
|  | Ended | Net | Income / | Total | Depr. And | Capital |
|  | Dec. 31, | Revenue | (Loss) | Assets | Amort. | Expenditures |
| Manufacturing | *2022* | $5044 | $301 | $15345 | $99 | $15 |
|  | *2021* | $3528 | (48) | 14799 | 104 | 35 |
| Testing Services | *2022* | 5648 | 547 | 27757 | 1111 | 2811 |
|  | *2021* | 4966 | 588 | 24546 | 644 | 322 |
| Distribution | *2022* | 1694 | 217 | 1437 |  |  |
|  | *2021* | 2420 | 277 | 1850 |  |  |
| Real Estate | *2022* | 4 | (28) | 1580 | 20 |  |
|  | *2021* | 8 | (28) | 1283 | 21 |  |
| Corporate & Unallocated | *2022* |  | 32 | 77 | 6 | 12 |
|  | *2021* |  | (133) | 74 |  |  |
| Total Company | *2022* | $12390 | $1069 | $46196 | $1236 | $2838 |
|  | *2021* | $10922 | 656 | 42552 | 769 | 357 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *14*-

------

***15***. **OTHER (EXPENSES) / INCOME**

Other (expenses) / income consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
|  | Dec. 31, | Dec. 31, | Dec. 31, | Dec. 31, |
|  | 2022 | 2021 | 2022 | 2021 |
|  | Unaudited | Unaudited | Unaudited | Unaudited |
| Interest income | $37 | $16 | $55 | $38 |
| Other rental income | 27 | 29 | 54 | 58 |
| Exchange loss | (349) | (38) | (279) | (4) |
| Bad debt recovery |  | 102 |  | 104 |
| Commission income |  | 200 |  | 200 |
| Government grant | 21 | 28 | 42 | 98 |
| Other miscellaneous income | 21 | 44 | 64 | 48 |
| **Total** | $**(243)** | $**381** | $**(64)** | $**542** |

---

***16.* INCOME TAX**

The Company is subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgment is required in determining the provision for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws. The statute of limitations, in general, is open for years *2016* to *2022* for tax authorities in those jurisdictions to audit or examine income tax returns. The Company is under annual review by the tax authorities of the respective jurisdiction to which the subsidiaries belong.

Due to the enactment of the Tax Act, the Company is subject to a tax on global intangible low-taxed income ("GILTI"). GILTI is a tax on foreign income in excess of a deemed return on tangible assets of foreign corporations. Companies subject to GILTI have the option to account for the GILTI tax as a period cost if and when incurred, or to recognize deferred taxes for temporary differences including outside basis differences expected to reverse as GILTI. The Company has elected to account for GILTI as a period cost. GILTI expense was $41 and $83 for the *three* and *six* months ended *December 31, 2022,* as compared to $23 and $46 for the same period in Fiscal *2022.*

The Company's income tax expense was $241 and $466 for the *three* and *six* months ended *December 31, 2022,* as compared to $153 and $333 for the same period in Fiscal *2022.* Our effective tax rate ("ETR") from continuing operations was 30.2% and 15.16% for the quarters ended *December 31, 2022* and *December 31, 2021,* respectively. The increase in income tax expense and effective tax rate was due to the following:

*1.* The Thailand operation incurred higher income tax due to higher income generated in period ended *December 31, 2022* compared to same period last fiscal year.

*2.* The Company recognized higher GILTI expenses due to higher income derived from controlled foreign corporation.

The Company accrues penalties and interest related to unrecognized tax benefits when necessary as a component of penalties and interest expense, respectively. The Company had no unrecognized tax benefits or related accrued penalties or interest expense at *December 31, 2022.*

In assessing the ability to realize the deferred tax assets, management considers whether it is more likely than *not* that some portion or all of the deferred tax assets will *not* be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on these criteria, management believes it is more likely than *not* the Company will *not* realize the benefits of the federal, state, and foreign deductible differences. Accordingly, a valuation allowance has been established against deferred tax assets recorded in the U.S. and various foreign jurisdictions.

***17.* REVENUE**

The Company generates revenue primarily from *3* different segments: Manufacturing, Testing and Distribution. The Company accounts for a contract with a customer when there is approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. The Company's revenues are measured based on consideration stipulated in the arrangement with each customer, net of any sales incentives and amounts collected on behalf of *third* parties, such as sales taxes. The revenues are recognized as separate performance obligations that are satisfied by transferring control of the product or service to the customer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *15*-

------

**Significant Judgments**

The Company's arrangements with its customers include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. A product or service is considered distinct if it is separately identifiable from other deliverables in the arrangement and if a customer can benefit from it on its own or with other resources that are readily available to the customer.

The Company allocates the transaction price to each performance obligation on a relative standalone selling price basis ("SSP"). Determining the SSP for each distinct performance obligation and allocation of consideration from an arrangement to the individual performance obligations and the appropriate timing of revenue recognition are significant judgments with respect to these arrangements. The Company typically establishes the SSP based on observable prices of products or services sold separately in comparable circumstances to similar clients. The Company *may* estimate SSP by considering internal costs, profit objectives and pricing practices in certain circumstances.

Warranties, discounts and allowances are estimated using historical and recent data trends. The Company includes estimates in the transaction price only to the extent that a significant reversal of revenue is *not* probable in subsequent periods. The Company's products and services are generally *not* sold with a right of return, nor has the Company experienced significant returns from or refunds to its customers.

**Manufacturing**

The Company primarily derives revenue from the sale of both front-end and back-end semiconductor test equipment and related peripherals, maintenance and support of all these products, installation and training services and the sale of spare parts. The Company's revenues are measured based on consideration stipulated in the arrangement with each customer, net of any sales incentives and amounts collected on behalf of *third* parties, such as sales taxes.

The Company recognizes revenue at a point in time when the Company has satisfied its performance obligation by transferring control of the product to the customer. The Company uses judgment to evaluate whether the control has transferred by considering several indicators, including:

● whether the Company has a present right to payment;

● the customer has legal title;

● the customer has physical possession;

● the customer has significant risk and rewards of ownership; and

● the customer has accepted the product, or whether customer acceptance is considered a formality based on history of acceptance of similar products (for example, when the customer has previously accepted the same equipment, with the same specifications, and when we can objectively demonstrate that the tool meets all the required acceptance criteria, and when the installation of the system is deemed perfunctory).

*Not* all indicators need to be met for the Company to conclude that control has transferred to the customer. In circumstances in which revenue is recognized prior to the product acceptance, the portion of revenue associated with its performance obligations of product installation and training services are deferred and recognized upon acceptance.

The majority of sales under the Manufacturing segment include a standard *12*-month warranty which are mainly assurance warranty and are *not* separate performance obligations. Warranty provided for some customized products *may* be classified as service warranties and are separate performance obligations. Transaction prices are allocated to this performance obligation using cost plus method. The portion of revenue associated with warranty service is deferred and recognized as revenue over the warranty period, as the customer simultaneously receives and consumes the benefits of warranty services provided by the Company.

**Testing**

The Company renders testing services to manufacturers and purchasers of semiconductors and other entities who either lack testing capabilities or whose in-house screening facilities are insufficient. The Company primarily derives testing revenue from burn-in services, manpower supply and other associated services. SSP is directly observable from the sales orders. Revenue is allocated to performance obligations satisfied at a point in time depending upon terms of the sales order. Generally, there is *no* other performance obligation other than what has been stated inside the sales order for each of these sales.

Terms of contract that *may* indicate potential variable consideration include warranty, late delivery penalty and reimbursement to solve nonconformance issues for rejected products. Based on historical and recent data trends, it is concluded that these terms of the contract do *not* represent potential variable consideration. The transaction price is *not* contingent on the occurrence of any future event.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *16*-

------

**Distribution**

The Company distributes complementary products, particularly equipment, industrial products and components by manufacturers mainly from the U.S., Europe and Taiwan. The Company recognizes revenue from product sales at a point in time when the Company has satisfied its performance obligation by transferring control of the product to the customer. The Company uses judgment to evaluate whether control has transferred by considering several indicators discussed above. The Company recognizes the revenue at a point in time, generally upon shipment or delivery of the products to the customer or distributors, depending upon terms of the sales order.

**Contract Balances**

The timing of revenue recognition, billings and collections *may* result in billed accounts receivable, unbilled receivables, contract assets, customer advances, deposits and contract liabilities. The Company's payment terms and conditions vary by contract type, although terms generally include a requirement of payment of *70%* to *90%* of total contract consideration within *30* to *60* days of shipment with the remainder payable within *30* days of acceptance. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that its contracts generally do *not* include a significant financing component.

The following table is the reconciliation of contract balances.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Dec. 31, | Dec. 31, | June 30, | June 30, |
|  | 2022 | 2022 | 2022 | 2022 |
|  | (Unaudited) | (Unaudited) |  |  |
| Trade Accounts Receivable |  | 13332 |  | 11592 |
| Accounts Payable |  | 3067 |  | 2401 |
| Contract Liabilities |  | 1282 |  | 988 |

---

**Remaining Performance Obligation**

As at *December 31, 2022,* the Company had $296 of remaining performance obligations, which represents our obligation to deliver products and services within two years.

As at *June 30, 2022,* the Company had $326 of remaining performance obligations, which represents our obligation to deliver products and services.

***18.* EARNINGS PER SHARE**

Options to purchase 636,375 shares of Common Stock at exercise prices ranging from $2.53 to $7.76 per share were outstanding as of *December 31, 2022.* 405,500 stock options were excluded in the computation of diluted earnings per share ("EPS") for the *three* months ended *December 31, 2022,* because they were anti-dilutive.

Options to purchase 724,500 shares of Common Stock at exercise prices ranging from $2.53 to $5.98 per share were outstanding as of *December 31, 2021.* 212,500 stock options were excluded in the computation of diluted EPS for the *three* months ended *December 31, 2021,* because they were anti-dilutive.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *17*-

------

The following table is a reconciliation of the weighted average shares used in the computation of basic and diluted EPS for the period presented herein:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
|  | Dec. 31, | Dec. 31, | Dec. 31, | Dec. 31, |
|  | 2022 | 2021 | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| Income attributable to Trio-Tech International common shareholders from continuing operations, net of tax | $512 | $856 | $1394 | $1770 |
| Income / (loss) attributable to Trio-Tech International common shareholders from discontinued operations, net of tax | (5) | (1) | (5) | 2 |
| **Net income attributable to Trio-Tech International Common Shareholders** | $**507** | $**855** | $**1389** | $**1772** |
| Weighted average number of common shares outstanding - basic | 4074 | 3923 | 4074 | 3923 |
| Dilutive effect of stock options | 88 | 319 | 86 | 206 |
| Number of shares used to compute earnings per share - diluted | 4162 | 4242 | 4160 | 4129 |
| Basic earnings per share from continuing operations attributable to Trio-Tech International | $0.12 | 0.22 | 0.34 | 0.46 |
| Basic earnings per share from discontinued operations attributable to Trio-Tech International |  |  |  |  |
| **Basic earnings per share from net income attributable to Trio-Tech International** | $**0.12** | $**0.22** | $**0.34** | $**0.46** |
| Diluted earnings per share from continuing operations attributable to Trio-Tech International | $0.12 | 0.20 | 0.33 | 0.43 |
| Diluted earnings per share from discontinued operations attributable to Trio-Tech International |  |  |  |  |
| **Diluted earnings per share from net income attributable to Trio-Tech International** | $**0.12** | $**0.20** | $**0.33** | $**0.43** |

---

***19.* STOCK OPTIONS**

On *September 24, 2007,* the Company's Board of Directors unanimously adopted the *2007* Employee Stock Option Plan (the *"2007* Employee Plan") and the *2007* Directors Equity Incentive Plan (the *"2007* Directors Plan" and, together with the *2007* Employee Plan, the *"2007* Plans"), each of which was approved by the shareholders on *December 3, 2007.* Each of the *2007* Plans were amended during the term of such plan to increase the number of shares covered thereby. Each of the *2007* Plans terminated by their respective terms on *September 24, 2017.*

On *September 14, 2017,* the Company's Board of Directors unanimously adopted the *2017* Employee Stock Option Plan (the *"2017* Employee Plan") and the *2017* Directors Equity Incentive Plan (the *"2017* Directors Plan") each of which was approved by the shareholders on *December 4, 2017.*

***Assumptions***

The fair value for the stock options granted to both employees and directors was estimated using the Black-Scholes option pricing model with the following weighted average assumptions, assuming:

● An expected life varying from 2.50 to 3.25 years, calculated in accordance with the guidance provided in SEC Staff bulletin *No. 110* for plain vanilla options using the simplified method, since our equity shares have been publicly traded for only a limited period of time and we did *not* have sufficient historical exercise data at the grant date of the options;

● A risk-free interest rate varying from 0.11% to 3.15% (*2022:* 0.11% to 2.35%);

● no expected dividend payments and;

● expected volatility of 47.3% to 73.85% (*2022:* 45.38% to 55.59%).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *18*-

------

***<u>*2017* Employee Stock Option Plan</u>***

The Company's *2017* Employee Plan permits the grant of stock options to its employees covering up to an aggregate of 300,000 shares of Common Stock. The Company's Board of Directors approved an amendment to the *2017* Employee Plan in *December, 2021* to increase the shares covered thereby from 300,000 shares to an aggregate of 600,000 shares, which amendment was approved by the Company's shareholders at the annual meeting held in *December 2021.* Under the *2017* Employee Plan, all options must be granted with an exercise price of *not* less than fair value as of the grant date and the options granted must be exercisable within a maximum of ten years after the date of grant, or such lesser period of time as is set forth in the stock option agreements. The options *may* be exercisable (a) immediately as of the effective date of the stock option agreement granting the option, or (b) in accordance with a schedule related to the date of the grant of the option, the date of *first* employment, or such other date as *may* be set by the Compensation Committee. Generally, options granted under the *2017* Employee Plan are exercisable within five years after the date of grant and vest over the period as follows: 25% vesting on the grant date and the remaining balance vesting in equal installments on the next *three* succeeding anniversaries of the grant date. The share-based compensation will be recognized in terms of the grade method on a straight-line basis for each separately vesting portion of the award. Certain option awards provide for accelerated vesting if there is a change in control (as defined in the *2017* Employee Plan).

During the *first two* quarters of Fiscal *2023,* 25,000 stock options were granted under the *2017* Employee Plan. There were 5,000 stock options exercised during the *six*-month period ended *December 31, 2022.* The Company recognized $54 in stock-based compensation expense during the *six* months ended *December 31, 2022.*

During the *first two* quarters of Fiscal *2022,* there were no stock options granted under the *2017* Employee Plan. There were 41,125 stock options exercised during the *six*-month period ended *December 31, 2021.* The Company recognized $22 stock-based compensation expenses during the *six* months ended *December 31, 2021.*

As of *December 31, 2022,* there were vested stock options granted under the *2017* Employee Plan covering a total of 134,500 shares of Common Stock. The weighted-average exercise price was $4.78 and the weighted average remaining contractual term was 1.73 years.

As of *December 31, 2021,* there were vested stock options granted under the *2017* Employee Plan covering a total of 130,375 shares of Common Stock. The weighted-average exercise price was $4.79 and the weighted average remaining contractual term was 2.00 years.

A summary of option activities under the *2017* Employee Plan during the *six* months period ended *December 31, 2022,* is presented as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | Weighted Average | Weighted Average Remaining Contractual | Aggregate |
|  |  | Exercise | Term | Intrinsic |
|  | Options | Price | (Years) | Value |
| Outstanding at July 1, 2022 | 236375 | $5.21 | 2.61 | $87 |
| Granted | 25000 | 5.18 | *-* | *-* |
| Exercised | (5000) | 3.75 | *-* | *-* |
| Forfeited or expired | (40000) | *-* | *-* | *-* |
| Outstanding at December 31, 2022 | 216375 | $5.16 | 2.49 | $96 |
| Exercisable at December 31, 2022 | 134500 | $4.78 | 1.73 | $75 |

---

A summary of the status of the Company's non-vested employee stock options during the *six* months ended *December 31, 2022,* is presented below:

---

| | | |
|:---|:---|:---|
|  |  | Weighted Average |
|  | Options | Grant-Date Fair Value |
| Non-vested at July 1, 2022 | 75875 | $5.98 |
| Granted | 25000 | 5.18 |
| Vested | (9000) | *-* |
| Forfeited | (10000) | *-* |
| Non-vested at December 31, 2022 | 81875 | $5.79 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *19*-

------

A summary of option activities under the *2017* Employee Plan during the *six* months period ended *December 31, 2021,* is presented as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | Weighted Average | Weighted Average Remaining Contractual | Aggregate |
|  |  | Exercise | Term | Intrinsic |
|  | Options | Price | (Years) | Value |
| Outstanding at July 1, 2021 | 267000 | $4.21 | 3.22 | $290 |
| Granted | *-* | *-* | *-* | *-* |
| Exercised | (41125) | 2.87 | *-* | *-* |
| Forfeited or expired | *-* | *-* | *-* | *-* |
| Outstanding at December 31, 2021 | 225875 | $4.46 | 2.66 | $2026 |
| Exercisable at December 31, 2021 | 130375 | $4.79 | 2.00 | $1127 |

---

A summary of the status of the Company's non-vested employee stock options during the *six* months period ended *December 31, 2021,* is presented below:

---

| | | |
|:---|:---|:---|
|  |  | Weighted Average |
|  | Options | Grant-Date Fair Value |
| Non-vested at July 1, 2021 | 102250 | $2.29 |
| Granted | *-* | *-* |
| Vested | (6750) | *-* |
| Forfeited | *-* | *-* |
| Non-vested at December 31, 2021 | 95500 | $2.29 |

---

***<u>*2007* Employee Stock Option Plan</u>***

The Company's *2007* Employee Plan permitted the issuance of options to employees. As of the last amendment thereof, the *2007* Employee Plan covered an aggregate of 600,000 shares of the Company's Common Stock. The *2007* Employee Plan terminated by its terms on *September 24, 2017* and no further options *may* be granted thereunder. Options outstanding thereunder continue to remain outstanding and in effect in accordance with their terms.

There were no options exercised during the *six* months ended *December 31, 2022,* and *December 31, 2021.* The Company did not recognize any stock-based compensation expense during the *six* months ended *December 31, 2022,* and *December 31, 2021.*

As of *July 1, 2022* and *December 31, 2022,* there were no vested or unvested stock options outstanding under the *2007* Employee Plan.

As of *December 31, 2021,* there were vested stock options granted under the *2007* Employee Plan covering a total of 37,500 shares of Common Stock. The weighted average exercise price was $4.14 and the weighted average remaining contractual term was 0.24 years.

A summary of option activities under the *2007* Employee Plan during the *six* months ended *December 31, 2021,* is presented as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | Weighted Average | Weighted Average Remaining Contractual | Aggregate |
|  |  | Exercise | Term | Intrinsic |
|  | Options | Price | (Years) | Value |
| Outstanding at July 1, 2021 | 37500 | $4.14 | 0.75 | $34 |
| Granted | *-* | *-* | *-* | *-* |
| Exercised | *-* | *-* | *-* | *-* |
| Forfeited or expired | *-* | *-* | *-* | *-* |
| Outstanding at December 31, 2021 | 37500 | $4.14 | 0.24 | $348 |
| Exercisable at December 31, 2021 | 37500 | $4.14 | 0.24 | $348 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *20*-

------

***<u>*2017* Directors Equity Incentive Plan</u>***

The *2017* Directors Plan initially covered an aggregate of 300,000 shares of the Company's common stock. The Company's Board of Directors approved an amendment to the *2017* Directors Plan in *September 2020* to increase the shares covered thereby from 300,000 shares to an aggregate of 600,000 shares, which amendment was approved by the Company's shareholders at the annual meeting held in *December 2020.* The *2017* Directors Plan permits the grant of options to its directors in the form of nonqualified options and restricted stock. The exercise price of the nonqualified options is required to be *100%* of the fair value of the underlying shares on the grant date. The options have five-year contractual terms and are exercisable immediately as of the grant date.

During the *first two* quarters of Fiscal *2023* and Fiscal *2022,* the Company did not grant any options pursuant to the *2017* Directors Plan. There were no stock options exercised and the Company did not recognize any stock-based compensation expense during the *six* months ended *December 31, 2022* and *2021.*

As all the stock options granted under the *2017* Directors Plan vest immediately on the date of grant, there were no unvested stock options granted under the *2017* Directors Plan as of *December 31, 2022,* or *December 31, 2021.*

As of *December 31, 2022,* there were vested stock options granted under the *2017* Directors Plan covering a total of 420,000 shares of Common Stock. The weighted average exercise price was $5.10 and the weighted average remaining contractual term was 2.34 years.

As of *December 31, 2021,* there were vested stock options granted under the *2017* Directors Plan covering a total of 320,000 shares of Common Stock. The weighted-average exercise price was $4.27 and the weighted average remaining contractual term was 2.72 years.

A summary of option activities under the *2017* Directors Plan during the *six* months ended *December 31, 2022,* is presented as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | Weighted Average | Weighted Average Remaining Contractual | Aggregate |
|  |  | Exercise | Term | Intrinsic |
|  | Options | Price | (Years) | Value |
| Outstanding at July 1, 2022 | 420000 | $5.10 | 2.85 | $228 |
| Granted | *-* | *-* |  | *-* |
| Exercised | *-* | *-* | *-* | *-* |
| Forfeited or expired | *-* | *-* | *-* | *-* |
| Outstanding at December 31, 2022 | 420000 | $5.10 | $2.34 | $255 |
| Exercisable at December 31, 2022 | 420000 | $5.10 | $2.34 | $255 |

---

A summary of option activities under the *2017* Directors Plan during the *six* months ended *December 31, 2021,* is presented as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | Weighted Average | Weighted Average Remaining Contractual | Aggregate |
|  |  | Exercise | Term | Intrinsic |
|  | Options | Price | (Years) | Value |
| Outstanding at July 1, 2021 | 320000 | $4.27 | 3.22 | $340 |
| Granted | *-* | *-* | *-* | *-* |
| Exercised | *-* | *-* | *-* | *-* |
| Forfeited or expired | *-* | *-* | *-* | *-* |
| Outstanding at December 31, 2021 | 320000 | 4.27 | 2.97 | $2933 |
| Exercisable at December 31, 2021 | 320000 | 4.27 | 2.97 | $2933 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *21*-

------

***<u>*2007* Directors Equity Incentive Plan</u>***

The Company's *2007* Directors Plan permitted the grant of stock options to its directors in the form of nonqualified options and restricted stock. As of the last amendment thereof, the *2007* Directors Plan covered an aggregate of 500,000 shares of the Company's Common Stock. The *2007* Directors Plan terminated by its terms on *September 24, 2017,* and no further options *may* be granted thereunder. Options outstanding thereunder continue to remain outstanding and in effect in accordance with their terms.

There were *no* stock options exercised during the *six* months ended *December 31, 2022* and *2021.* The Company did not recognize any stock-based compensation expense during the *six* months ended *December 31, 2022* and *2021.*

As of *July 1, 2022* and *December 31, 2022,* there were no vested stock options granted under the *2007* Directors Plan.

As of *December 31, 2021,* there were vested stock options granted under the *2007* Directors Plan covering a total of 50,000 shares of Common Stock. The weighted-average exercise price was $4.14 and the weighted average remaining contractual term was 0.24 years.

A summary of option activities under the *2007* Directors Plan during the *six* months ended *December 31, 2021* is presented as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | Weighted Average | Weighted Average Remaining Contractual | Aggregate |
|  |  | Exercise | Term | Intrinsic |
|  | Options | Price | (Years) | Value |
| Outstanding at July 1, 2021 | 50000 | $4.14 | 0.75 | $45 |
| Granted | *-* | *-* | *-* | *-* |
| Exercised |  |  | *-* | *-* |
| Forfeited or expired |  |  | *-* | *-* |
| Outstanding at December 31, 2021 | 50000 | $4.14 | 0.24 | $465 |
| Exercisable at December 31, 2021 | 50000 | $4.14 | 0.24 | $465 |

---

***20.* LEASES**

***Company as Lessor***

Operating leases under which the Company is the lessor arise from leasing the Company's commercial real estate investment property to *third* parties. Initial lease terms generally range from 12 to 60 months. Depreciation expense for assets subject to operating leases is taken into account primarily on the straight-line method over a period of twenty years in amounts necessary to reduce the carrying amount of the asset to its estimated residual value. Depreciation expense relating to the property held as investments in operating leases were $38 and $41 for *three* months ended *December 31, 2022,* and *December 31, 2021,* respectively.

Future minimum rental income in China and Thailand to be received from Fiscal *2023* to the fiscal year ended *June 30, 2027 (*"Fiscal *2027"*) on noncancelable operating leases is contractually due as follows as of *December 31, 2022:*

---

| | |
|:---|:---|
| Remainder of Fiscal 2023 | $60 |
| Fiscal 2024 | 130 |
| Fiscal 2025 | 131 |
| Fiscal 2026 | 44 |
| Fiscal 2027 | 15 |
|  | $**380** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *22*-

------

Future minimum rental income in China and Thailand to be received from Fiscal *2023* to Fiscal *2027* on non-cancelable operating leases is contractually due as follows as of *June 30, 2022:*

---

| | |
|:---|:---|
| 2023 | $6 |
| 2024 | $27 |
| 2025 | $28 |
| 2026 | $29 |
| 2027 | $10 |
|  | $**100** |

---

Sales-type leases under which the Company is the lessor arise from the lease of four units of chiller systems. The Company classifies its lease arrangements at inception of the arrangement. The lease term is three years, contains an automatic transfer of title at the end of the lease term and a guarantee of residual value at the end of the lease term. The customer is required to pay for executory costs such as taxes.

Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales of four units of chiller systems are as follows:

---

| | |
|:---|:---|
| **Components of Lease Balances** | Dec. 31, |
|  | 2022 |
| **Assets**  |  |
| Gross financial sales receivable | $28 |
| Unearned finance income | (1) |
| Financed sales receivable | $27 |
| **Net financed sales receivables due within one year**  | $21 |
| **Net financed sales receivables due after one year**  | $6 |

---

As of *December 31, 2022,* the financed sale receivables had a weighted average effective interest rate of 11.16% and weighted average remaining lease term of 1.25 years.

***Company as Lessee***

The Company is the lessee under operating leases for corporate offices and research and development facilities with remaining lease terms of one year to four years and finance leases for plant and equipment.

Supplemental balance sheet information related to leases was as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | Dec. 31, | June 30, |
|  | 2022 | 2022 |
|  | (Unaudited) |  |
| **Finance Leases (Plant and Equipment)** |  |  |
| Plant and equipment, at cost | $1751 | $1727 |
| Accumulated depreciation | (1289) | (1179) |
| **Plant and Equipment, Net**  | $462 | $548 |
| Current portion of finance leases | $101 | $118 |
| Net of current portion of finance leases | 69 | 119 |
| **Total Finance Lease Liabilities** | $170 | $237 |
| **Operating Leases (Corporate Offices, Research and Development Facilities)** |  |  |
| Operating lease right-of-use assets | $2580 | $3152 |
| **Operating lease right-of-use assets, Net**  | $2580 | $3152 |
| Current portion of operating leases | 1140 | 1218 |
| Net of current portion of operating leases | 1440 | 1934 |
| **Total Operating Lease Liabilities** | $2580 | $3152 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended | Three Months Ended | Six Months Ended |  |
|  | Dec. 31, | Dec. 31, | Dec. 31, | Dec. 31, |
|  | 2022 | 2021 | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| Lease Cost |  |  |  |  |
| Finance lease cost: |  |  |  |  |
| Interest on finance lease | $3 | $5 | $6 | $11 |
| Amortization of right-of-use assets | 44 | 62 | 92 | 90 |
| Total finance lease cost | 47 | 67 | 98 | 101 |
| Operating Lease Costs | $369 | $231 | $749 | $470 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *23*-

------

Other information related to leases was as follows (in thousands except lease term and discount rate):

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31, | Dec. 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| **Cash Paid for Amounts Included in the Measurement of Lease Liabilities** |  |  |
| Operating cash flows from finance leases | $6 | $13 |
| Operating cash flows from operating leases | 594 | 470 |
| **Right-of-Use Assets Obtained in Exchange for New Operating Lease Liabilities** |  |  |
| **Weighted-Average Remaining Lease Term:** |  |  |
| Finance leases | 1.59 | 2.69 |
| Operating leases | 2.67 | 3.57 |
| **Weighted-Average Discount Rate:** |  |  |
| Finance leases | 3.22% | 3.50% |
| Operating leases | 5.54% | 4.81% |

---

As of *December 31, 2022,* the maturities of the Company's operating and finance lease liabilities are as follow:

---

| | | |
|:---|:---|:---|
|  | **Operating Lease Liabilities** | **Finance Lease Liabilities** |
| **Fiscal Year** |  |  |
| Remainder of Fiscal 2023 | $650 | $54 |
| 2024 | 1074 | 105 |
| 2025 | 577 | 21 |
| 2026 | 414 |  |
| Thereafter | 67 |  |
| **Total future minimum lease payments**  | $2782 | $180 |
| Less: amount representing interest | (202) | (10) |
| **Present value of net minimum lease payments**  | $2580 | $170 |
| **Presentation on statement of financial position** |  |  |
| Current | 1140 | 101 |
| Non-Current | 1440 | 69 |

---

As of *June 30, 2022,* future minimum lease payments under finance leases and noncancelable operating leases were as follows:

---

| | | |
|:---|:---|:---|
|  | **Operating Lease Liabilities** | **Finance Lease Liabilities** |
| **Fiscal Year** |  |  |
| 2023 | $1357 | $129 |
| 2024 | 1032 | 104 |
| 2025 | 554 | 20 |
| 2026 | 423 |  |
| Thereafter | 69 |  |
| **Total future minimum lease payments**  | $3435 | $253 |
| Less: amount representing interest | (283) | (16) |
| **Present value of net minimum lease payments**  | $3152 | $237 |
| **Presentation on statement of financial position** |  |  |
| Current | 1218 | 118 |
| Non-Current | 1934 | 119 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *24*-

------

***21.* FAIR VALUE OF FINANCIAL INSTRUMENTS** 

In accordance with ASC Topics *825* and *820,* the following presents assets and liabilities measured and carried at fair value and classified by level of fair value measurement hierarchy:

There were *no* transfers between Levels *1* and *2* during the *six* months ended *December 31, 2022* and *2021.*

Term deposits (Level *2*) – The carrying amount approximates fair value because of the short maturity of these instruments.

Restricted term deposits (Level *2*) – The carrying amount approximates fair value because of the short maturity of these instruments.

Lines of credit (Level *3*) – The carrying value of the lines of credit approximates fair value due to the short-term nature of the obligations.

Bank loans payable (Level *3*) – The carrying value of the Company's bank loans payable approximates its fair value as the interest rates associated with long-term debt is adjustable in accordance with market situations when the Company borrowed funds with similar terms and remaining maturities.

***22.* CONCENTRATION OF CUSTOMERS** 

The Company had two major customers mainly contributed to manufacturing and testing segments that accounted for the following revenue and trade account receivables:

---

| | | |
|:---|:---|:---|
|  | Six Months Ended Dec. 31, | Six Months Ended Dec. 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| **Revenue** |  |  |
| - Customer A | 34.7% | 42.8% |
| - Customer B | 15.3% | 5.3% |
| &nbsp;&nbsp;&nbsp;- Customer C | 13.3% | 15.6% |
| **Trade Account Receivables** |  |  |
| - Customer A | 32.1% | 40.1% |
| - Customer B | 15.6% | 6.1% |
| &nbsp;&nbsp;&nbsp;- Customer C | 17.3% | 16.7% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *25*-

------

**TRIO-TECH INTERNATIONAL AND SUBSIDIARIES**

**ITEM 2. MANAGEMENT**'**S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)**

**Overview**

*The following should be read in conjunction with the condensed consolidated financial statements and notes in Item I above and with the audited consolidated financial statements and notes, the information under the headings* "*Management*'*s discussion and analysis of financial condition and results of operations*" *in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.*

Trio-Tech International ("TTI") was incorporated in 1958 under the laws of the State of California. As used herein, the term "Trio-Tech" or "Company" or "we" or "us" or "Registrant" includes Trio-Tech International and its subsidiaries unless the context otherwise indicates. Our mailing address and executive offices are located at Block 1008 Toa Payoh North, Unit 03-09 Singapore 318996, and our telephone number is (65) 6265 3300.

The Company is a provider of reliability test equipment and services to the semiconductor industry. Our customers rely on us to verify that their semiconductor components meet or exceed the rigorous reliability standards demanded for aerospace, communications and other electronics products.

During the six months ended December 31, 2022, TTI generated approximately 99.9% of its revenue from its three core business segments in the test and measurement industry, i.e., manufacturing of test equipment ("Manufacturing"), testing services ("Testing") and distribution of test equipment ("Distribution"). The Real Estate segment contributed only 0.01% to the total revenue during the six months ended December 31, 2022.

**Manufacturing**

TTI develops and manufactures an extensive range of test equipment used in the "front-end" and the "back-end" manufacturing processes of semiconductors. Our equipment includes leak detectors, autoclaves, centrifuges, burn-in systems and boards, HAST testers, temperature-controlled chucks, wet benches and more.

**Testing**

TTI provides comprehensive electrical, environmental, and burn-in testing services to semiconductor manufacturers in our testing laboratories in Asia and the United States ("U.S."). Our customers include both manufacturers and end users of semiconductor and electronic components who look to us when they do not want to establish their own facilities. The independent tests are performed to industry and customer specific standards.

**Distribution**

In addition to marketing our proprietary products, we distribute complementary products made by manufacturers mainly from the U.S., Europe, and Taiwan. The products include environmental chambers, handlers, interface systems, vibration systems, shaker systems, solderability testers and other semiconductor equipment. Besides equipment, we also distribute a wide range of components such as connectors, sockets, LCD display panels and touch screen panels. Furthermore, our range of products are mainly targeted for industrial products rather than consumer products whereby the life cycle of the industrial products can last from three years to seven years.

**Real Estate**

Our real estate segment generates investment income from the investments made and rental revenue received from real estate that we purchased in Chongqing, China.

***Critical Accounting Estimates & Policies***

The preparation of our Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions in applying our accounting policies that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base these estimates and assumptions on historical experience and evaluate them on an ongoing basis to ensure that they remain reasonable under current conditions. Actual results could differ from those estimates. We discuss the development and selection of the critical accounting estimates with the Audit Committee of our Board of Directors on a quarterly basis, and the Audit Committee has reviewed our related disclosure in this Quarterly Report on Form 10-Q.

There have been no material changes in our critical accounting estimates and policies since our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Refer to Note 1 "Basis of Presentation and Summary of significant Accounting Policies" to our Condensed Consolidated Financial Statements for additional details. In addition, please refer to "Management's Discussion and Analysis of Financial Condition and Results of Operations" contained in Part II, Item 7 of our Annual Report on Form 10-K for our fiscal year ended June 30, 2022 for a complete description of our critical accounting policies and estimates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -26-

------

**<u>Second Quarter Fiscal Year 2023 Highlights</u>**

● Total revenue increased by $1,468, or 13.4%, to $12,390 in the second quarter of our fiscal year ending June 30, 2023 ("Fiscal 2023"), compared to $10,922 for the same period in the fiscal year ended June 30, 2022 ("Fiscal 2022").

● Manufacturing segment revenue increased by $1,516, or 43%, to $5,044 in the second quarter of Fiscal 2023, compared to $3,528 for the same period in Fiscal 2022.

● Testing segment revenue increased by $682, or 13.7%, to $5,648 in the second quarter of Fiscal 2023, compared to $4,966 for the same period in Fiscal 2022.

● Distribution segment revenue decreased by $726, or 30%, to $1,694 in the second quarter of Fiscal 2023, compared to $2,420 for the same period in Fiscal 2022.

● Real estate segment rental revenue decreased by $4, or 50%, to $4 in the second quarter of Fiscal 2023, compared to $8 for the same period in Fiscal 2022.

● The overall gross profit margin increased by 0.4% to 26.9% in the second quarter of Fiscal 2023, from 26.5% for the same period in Fiscal 2022.

● General and administrative expense decreased by $28, or 1.5%, to $1,919 in the second quarter of Fiscal 2023, from $1,947 for the same period in Fiscal 2022.

● Selling expense increased by $37, or 34.6%, to $193 in the second quarter of Fiscal 2023, from $156 for the same period in Fiscal 2022.

● Other income decreased by $624, or 163.8%, to other expenses of $243 in the second quarter of Fiscal 2023, from other income of $381 for the same period in Fiscal 2022.

● Income from operations was $1,069 for the second quarter of Fiscal 2023, an increase of $413 as compared to $656 for the same period in Fiscal 2022.

● Income tax expense was $241 for the second quarter of Fiscal 2023, an increase of $88 as compared to $153 in the same period in Fiscal 2022.

● During the second quarter of Fiscal 2023, income from continuing operations before non-controlling interest, net of tax was $575, as compared to income from continuing operations before non-controlling interest of $856 for the same period in Fiscal 2022.

● Net income attributable to non-controlling interest for the second quarter of Fiscal 2023 was $58, an increase of $57 as compared to $1 in the same period in Fiscal 2022.

● Basic earnings per share for the second quarter of Fiscal 2023 was $0.12, as compared to earnings per share of $0.22 for the same period in Fiscal 2022.

● Diluted earnings per share for the second quarter of Fiscal 2023 was $0.12, as compared to earnings per share of $0.20 for the same period in Fiscal 2022.

● Total assets increased by $2,775 to $46,196 as of December 31, 2022, compared to $43,421 as of June 30, 2022.

● Total liabilities increased by $804 to $16,223 as of December 31, 2022, compared to $15,419 as of June 30, 2022.

**Results of Operations and Business Outlook**

The following table sets forth our revenue components for both three and six months ended December 31, 2022 and 2021.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Revenue Components** | Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended |
|  | Dec. 31, | Dec. 31, | Dec. 31, | Dec. 31, |
|  | 2022 | 2021 | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| Manufacturing | 40.7% | 32.3% | 35.5% | 33.6% |
| Testing Services | 45.6 | 45.4 | 49.4 | 45.4 |
| Distribution | 13.7 | 22.2 | 15.1 | 20.9 |
| Real Estate |  | 0.1 |  | 0.1 |
| Total | 100% | 100.0% | 100% | 100.0% |

---

Revenue for the three and six months ended December 31, 2022, was $12,390 and $24,329, respectively, an increase of $1,468 and $3,236, respectively, when compared to the revenue for the same period of Fiscal 2022. As a percentage, revenue increased by 13.4% and 15.3% for the three and six months ended December 31, 2022, when compared to revenue for the same period of Fiscal 2022.

For the three and six months ended December 31, 2022, there was an increase in revenue in the Testing and Manufacturing segments when compared to the same period of Fiscal 2022. The Distribution segment's revenue decreased compared to the same period of Fiscal 2022.

Total revenue into and within China, the Southeast Asia regions and other countries (except revenue into and within the U.S.) increased by $1,413 (or 13.2%), to $12,067 and by $3,187 (or 15.7%) to $23,513 for the three and six months ended December 31, 2022, respectively, as compared with $10,654 and $20,326 for the same period of Fiscal 2022, respectively.

Total revenue into and within the U.S. was $321 and $814 for the three and six months ended December 31, 2022, respectively, an increase of $53 and $47 from $268 and $767 for the same periods of Fiscal 2022, respectively.

Revenue within our four current segments for the three and six months ended December 31, 2022, is discussed below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -27-

------

***Manufacturing Segment***

Revenue in the Manufacturing segment as a percentage of total revenue was 40.7% and 35.5% for the three and six months ended December 31, 2022, respectively, an increase of 8.4% and 1.9% of total revenue when compared to 32.3% and 33.6% in the same period of Fiscal 2022. The revenue increased by $1,516 to $5,044 from $3,528 and increased by $1,539 to $8,629 from $7,090 for the three and six months ended December 31, 2022, respectively.

Revenue in the Manufacturing segment from one customer accounted for 38.0% and 50.9% of our total revenue in the Manufacturing segment for the three months ended December 31, 2022 and 2021, respectively, and 28.2% and 42.0% of our total revenue in the Manufacturing segment for the six months ended December 31, 2022, and 2021, respectively.

***Testing Services Segment***

The Testing segment's revenue was 45.6% for the three months ended December 31, 2022, representing a marginal increase of 0.2%, compared to 45.4% for the same period of Fiscal 2022. Revenue in the Testing segment was 49.4% as a percentage of total revenue for the six months ended December 31, 2022, an increase of 4% compared to the same period of Fiscal 2022. Total revenue increased by $682 to $5,648 and increased by $2,446 to $12,012 from $4,966 and $9,566 for the three and six months ended December 31, 2022, respectively, as compared to the same periods of Fiscal 2022.

The revenue in the Testing segment from one customer accounted for 40.9% and 63.0% of our revenue in the Testing segment for the three months ended December 31, 2022 and 2021, respectively, and 45.6% and 63.3% of our total revenue in the Testing segment for the six months ended December 31, 2022 and 2021, respectively. The future revenue in the Testing segment will be affected by the demands of this customer if the customer base cannot be increased. Demand for testing services varies from country to country, depending on any changes taking place in the market and our customers' forecasts. As it is challenging to forecast fluctuations in the market accurately, management believes it is necessary to maintain testing facilities in close proximity to the customers in order to make it convenient for them to send us their newly manufactured parts for testing and to enable us to maintain a share of the market.

***Distribution Segment***

Revenue in the Distribution segment was 13.7% and 15.1% as a percentage of total revenue for the three and six months ended December 31, 2022, respectively, a decrease of 8.5% and 5.8%, compared to the same period of Fiscal 2022. Total revenue decreased by $726 to $1,694 and decreased by $742 to $3,676 from $2,420 and $4,418 for the three and six months ended December 31, 2022, respectively, compared to the same period of Fiscal 2022.

The revenue in the Distribution segment from one customer accounted for 78.9% and 80.8% of our revenue in the Distribution segment for the three months ended December 31, 2022 and 2021, respectively, and 82.4% and 74.4% of our total revenue in the Distribution segment for the six months ended December 31, 2022 and 2021, respectively. Demand for the Distribution segment varies depending on the demand for our customers' products, the changes taking place in the market, and our customers' forecasts. Hence it is difficult to forecast fluctuations in the market accurately.

***Real Estate Segment***

The Real Estate segment revenue decreased to $4 and $12 from $8 and $19 for the three and six months ended December 31, 2022, compared to the same period of Fiscal 2022.

***Uncertainties and Remedies***

There are several influencing factors which create uncertainties when forecasting performance, such as the constantly changing nature of technology, specific requirements from the customer, decline in demand for certain types of burn-in devices or equipment, decline in demand for testing services and fabrication services, and other similar factors. One factor that influences uncertainty is the highly competitive nature of the semiconductor industry. Another is that some customers are unable to provide a forecast of the products required in the upcoming weeks; hence it is difficult to plan for the resources needed to meet these customers' requirements due to short lead time and last-minute order confirmation. This will normally result in a lower margin for these products as it is more expensive to purchase materials in a short time frame. However, the Company has taken certain actions and formulated certain plans to deal with and to help mitigate these unpredictable factors. For example, in order to meet manufacturing customers' demands upon short notice, the Company maintains higher inventories but continues to work closely with its customers to avoid stockpiling. We believe that we have improved customer service through our efforts to keep our staff up to date on the newest technology and stressing the importance of understanding and meeting the stringent requirements of our customers. Finally, the Company is exploring new markets and products, looking for new customers, and upgrading and improving burn-in technology while at the same time searching for improved testing methods for higher technology chips.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -28-

------

The Company's primary exposure to movements in foreign currency exchange rates relates to non-U.S. dollar-denominated sales and operating expense in its subsidiaries. Strengthening of the United States dollar ("U.S. Dollar") relative to foreign currencies adversely affects the U.S. Dollar value of the Company's foreign currency-denominated sales and earnings, and generally leads the Company to raise international pricing, potentially reducing demand for the Company's products. Margins on sales of the Company's products in foreign countries and on sales of products that include components obtained from foreign suppliers could be materially adversely affected by foreign currency exchange rate fluctuations. In some circumstances, for competitive or other reasons, the Company may decide not to raise local prices to fully offset the U.S. Dollar's strengthening, or at all, which would adversely affect the U.S. Dollar value of the Company's foreign currency-denominated sales and earnings. Conversely, a strengthening of foreign currencies relative to the U.S. Dollar, while generally beneficial to the Company's foreign currency denominated sales and earnings, could cause the Company to reduce international pricing, thereby limiting the benefit. Additionally, strengthening of foreign currencies may also increase the Company's cost of product components denominated in those currencies, thus adversely affecting gross margins.

As of December 2022, although we have seen improvements in both our operations and those of our suppliers, we may continue to experience supply shortages as well as inflationary cost pressures in at least the near term. Risks and uncertainties related to the COVID-19 pandemic, supply chain challenges, and inflationary pressures may continue to negatively impact our revenue and gross margin. We continue to monitor and evaluate the business impact to react proactively.

On August 9, 2022, the CHIPS and Science Act of 2022 (CHIPS Act) was enacted in the United States. The CHIPS Act will provide financial incentives to the semiconductor industry which are primarily directed at manufacturing activities within the United States. We continue to evaluate the business impact and potential opportunities related to the CHIPS Act. As of date, we do not see any direct effect of the CHIPS Act on the Company in the foreseeable future.

There are legal and operational risks associated with having operations in China. These risks could result in a material change in our operations and/or the value of our common stock or could limit or hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless. In recent past, the Peoples Republic of China ("PRC") government initiated a series of regulatory actions and statements to regulate business operations in China with little advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over China-based companies listed overseas using variable interest entity structure, adopting new measures to extend the scope of cybersecurity reviews, and expanding the efforts in anti-monopoly enforcement.

The Company and its subsidiaries do not have any variable interest entities based in China. Our business primarily consists of semiconductor testing and burn-in services for the automotive industry, avionics, and others. Our businesses are not impacted by anti-monopoly policies, variable interest entities policies, or data security policies, nor are our businesses subject to extraordinary oversight from the Chinese government.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -29-

------

**Comparison of the Three Months Ended December 31, 2022, and December 31, 2021**

The following table sets forth certain consolidated statements of income data as a percentage of revenue for the three months ended December 31, 2022 and 2021 respectively:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| **Revenue** | **100.0%** | **100.0%** |
| Cost of sales | 73.1% | 73.5% |
| **Gross Margin** | 26.9**%** | **26.5%** |
| Operating expense |  |  |
| General and administrative | 15.5% | 17.8% |
| Selling | 1.6% | 1.4% |
| Research and development | 1.2% | 1.2% |
| Total operating expense | 18.3% | 20.4% |
| **Income from Operations** | 8.6**%** | **6.1%** |

---

***Overall Gross Margin* **

Overall gross margin as a percentage of revenue increased by 0.4% to 26.9% for the three months ended December 31, 2022, from 26.5% for the same period of Fiscal 2022. Gross profits increased by $445 to $3,335 for the three months ended December 31, 2022, from $2,890 for the same period in Fiscal 2022.

Gross profit margin as a percentage of revenue in the Manufacturing segment increased by 5.2% to 23.7% for the three months ended December 31, 2022, as compared to 18.5% for the same period in Fiscal 2022. Gross profits in the Manufacturing segment increased by $541 to $1,195 for the three months ended December 31, 2022, from $654 for the same period in Fiscal 2022. The increase in gross profit margin was primarily due to a higher proportion of high profit margin product sales for the three months ended December 31, 2022 compared to the same period of Fiscal 2022.

Gross profit margin as a percentage of revenue in the Testing segment decreased by 4.1% to 33.7% for the three months ended December 31, 2022, compared to 37.8% in the same period of Fiscal 2022. The decrease in gross profit margin percentage was mainly due to lower margins in the Singapore and Tianjin testing operations resulting from lower demand due to inventory corrections made by customers in the second quarter of Fiscal 2023. In absolute dollar amounts, gross profit in the testing segment increased by $24 to $1,901 for the three months ended December 31, 2022, from $1,877 for the same period of Fiscal 2022.

Gross profit margin of the Distribution segment is not only affected by the market price of the products we distribute, but also the mix of products we distribute, which frequently changes as a result of fluctuations in market demand. Gross profit margin as a percentage of revenue in the Distribution segment decreased by 0.4% to 14.9% for the three months ended December 31, 2022, from 15.3% in the same period of Fiscal 2022. Gross profit in the Distribution segment for the three months ended December 31, 2022, was $253, a decrease of $117, compared to $370 in the same period of Fiscal 2022.

For the three months ended December 31, 2022, gross loss in the Real Estate segment was $14, as compared to $11 for the same period of Fiscal 2022.

***Operating Expense***

Operating expense for the three months ended December 31, 2022 and 2021 was as follows:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| General and administrative | $1919 | $1947 |
| Selling | 193 | 156 |
| Research and development | 151 | 131 |
| Gain on disposal of property, plant and equipment | 3 |  |
| **Total** | $**2266** | $**2234** |

---

General and administrative expense decreased by $28 or 1.5%, from $1,947 to $1,919 for the three months ended December 31, 2022, compared to the same period of Fiscal 2022. The decrease in general and administrative expense was mainly attributable to the bonus provision adjustments in this quarter that offset the increase of administrative expense relating to the Company's new subsidiary Trio-Tech Jiangsu, which was setup in the third quarter of Fiscal 2022.

Selling expense increased by $37, or 23.7%, from $156 to $193 for the three months ended December 31, 2022, compared to the same period of Fiscal 2022. The increase in selling expense was primarily attributable to an increase in commission costs in the Manufacturing segment of the Singapore operations as a result of an increase in commissionable revenue, and an increase in travel costs due to increased business travel in the second quarter of Fiscal 2023, compared to the same quarter of Fiscal 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -30-

------

***Income from Operations***

Income from operations was $1,052 for the three months ended December 31, 2022, an increase of $396, compared to profit of $656 from operations for the same period of Fiscal 2022. This was mainly due to higher revenue and improved gross profit margin from Manufacturing and Testing segments.

***Interest Expense***

Interest expense for the three months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| Interest expense | $10 | $28 |

---

Interest expense was $10 for the three months ended December 31, 2022, a decrease of $18, or 64.3%, compared to $28 for the same period of Fiscal 2022. As of December 31, 2022, the Company had an unused line of credit of $6,139 as compared to $5,207 at December 31, 2021.

***Other (Expense) / Income***

Other (expense) / income for the three months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| Interest income | $37 | $16 |
| Other rental income | 27 | 29 |
| Exchange loss | (349) | (38) |
| Bad debt recovery |  | 102 |
| Commission income |  | 200 |
| Government grant | 21 | 28 |
| Other miscellaneous income | 21 | 44 |
| **Total** | $(243) | $381 |

---

Other income decreased by $624 from $381 to other expense of $243 for the three months ended December 31, 2022 compared to the same period in Fiscal 2022. The decrease was mainly contributed by a negative foreign currency impact in the second quarter of Fiscal 2023 and the absence of one-time commission income that was earned in the same period in Fiscal 2022.

Our net income is impacted by the overall strengthening or weakening of the U.S. Dollars since the functional currency of our foreign subsidiaries is not U.S. Dollars. During the three months ended December 31, 2022, exchange rate movement negatively impacted our net income due to the strengthening of the Singapore dollars against the U.S. Dollars.

***Income Tax Expense***

The Company's income tax expense was $241 and $153 for the three months ended December 31, 2022, and 2021, respectively. The increase was primarily due to the increase in taxable income.

***Non-controlling Interest***

As of December 31, 2022, we held a 55% interest in Trio-Tech (Malaysia) Sdn. Bhd., Trio-Tech (Kuala Lumpur) Sdn. Bhd., SHI International Pte. Ltd., and 52% interest in PT. SHI Indonesia. We also held a 76% interest in Prestal Enterprise Sdn. Bhd and 51% interest in Trio-Tech JiangSu Co. Ltd. The share of non-controlling interest in the net profit from the subsidiaries for the three months ended December 31, 2022 was $58, an increase of $57 compared to the share of non-controlling interest in the net income from the subsidiaries of $1 for the same period of Fiscal 2022. The increase in the net income shared by non-controlling interest in the subsidiaries was attributable to the increase in net income generated by the China operation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -31-

------

***Net Income Attributable to Trio-Tech International Common Shareholders***

Net income attributable to Trio-Tech International common shareholders for the three months ended December 31, 2022, was $507, a change of $348, compared to a net income of $855 for the same period Fiscal 2022.

***Earnings per Share***

Basic earnings per share from continuing operations were $0.12 for the three months ended December 31, 2022, compared to $0.22 for the same period in Fiscal 2022. Basic earnings per share from discontinued operations were $nil for both the three months ended December 31, 2022 and 2021.

Diluted earnings per share from continuing operations were $0.12 for the three months ended December 31, 2022, as compared to $0.20 for the same period in Fiscal 2022. Diluted earnings per share from discontinued operations were $nil for both the three months ended December 31, 2022 and 2021.

**Segment Information**

The revenue, gross margin and income or loss from operations for each segment during the first quarter of Fiscal 2023 and Fiscal 2022 are presented below. As the revenue and gross margin for each segment have been discussed in the previous section, only the comparison of income or loss from operations is discussed below.

***Manufacturing Segment***

The revenue, gross margin and income from operations for the Manufacturing segment for the three months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| **Revenue** | $5044 | $3528 |
| **Gross margin** | 23.7% | 18.5% |
| **Income / (loss) from operations** | $301 | $(48) |

---

Income from operations from the Manufacturing segment was $301 compared to loss from operations of $48 in the same period of Fiscal 2022, primarily due to an increase in gross profit margin offset by an increase in operating expense of $315. Operating expense for the Manufacturing segment were $894 and $701 for the three months ended December 31, 2022 and 2021, respectively. The increase in operating expense was mainly due to an increase of $76 in general and administrative expense, $52 in selling expense and an increase of $29 in corporate overhead expense.

***Testing Segment***

The revenue, gross margin and income from operations for the Testing segment for the three months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| **Revenue** | $5648 | $4966 |
| **Gross margin** | 33.7% | 37.8% |
| **Income from operations** | $547 | $588 |

---

Income from operations in the Testing segment for the three months ended December 31, 2022 was $547 compared to $588 in the same period of Fiscal 2022, was mainly attributable to an increase of operating expenses. Operating expense was $1,354 and $1,290 for the three months ended December 31, 2022 and 2021, respectively. The increase of $64 in operating expense was mainly due to an increase of $124 in general and administrative expense while offset by decrease in selling expense and corporate expense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -32-

------

***Distribution Segment***

The revenue, gross margin and income from operations for the Distribution segment for the three months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| **Revenue** | $1694 | $2420 |
| **Gross margin** | 14.9% | 15.3% |
| **Income from operations** | $217 | $277 |

---

Income from operations in the Distribution segment for three months ended December 31, 2022 was $217, compared to $277 for the same period of Fiscal 2022. The decrease of $60 was mainly due to lower sales, thereby reducing the gross profit. Operating expense were $36 and $92 for the three months ended December 31, 2022 and 2021, respectively.

***Real Estate Segment***

The revenue, gross margin and loss from operations for the Real Estate segment for the three months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| **Revenue** | $4 | $8 |
| **Gross margin** | (350.0)% | (137.5)% |
| **Loss from operations** | $(28) | $(28) |

---

Loss from operations in the Real Estate segment was $28 for the three months ended December 31, 2022 and for the same period of Fiscal 2022. Operating expense was $14 and $17 for the three months ended December 31, 2022 and 2021, respectively.

***Corporate***

The income / (loss) from operations for Corporate for the three months ended December 31, 2022, and 2021 was as follows:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | December 31, | December 31, |
|  | 2022 | 2021 |
|  | (Unaudited) | (Unaudited) |
| **Income / (Loss) from operations** | $32 | $(133) |

---

Corporate operating profit was $32 for the three months ended December 31, 2022, compared to loss of $133 in the same period of Fiscal 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -33-

------

**Comparison of the Six Months Ended December 31, 2022, and December 31, 2021** 

The following table sets forth certain consolidated statements of income data as a percentage of revenue for the six months ended December 31, 2022 and 2021, respectively:

---

| | | | |
|:---|:---|:---|:---|
|  | Six Months Ended | Six Months Ended | Six Months Ended |
|  | Dec. 31,<br> 2022 | Dec. 31,<br> 2022 | Dec. 31,<br> 2021 |
| **Revenue** |  | **100.0%** | **100.0%** |
| Cost of sales |  | 71.4 | 71.2 |
| **Gross Margin** |  | **28.6%** | **28.8%** |
| Operating expenses: |  |  |  |
| General and administrative |  | 17.4% | 18.6% |
| Selling |  | 1.5 | 1.4 |
| Research and development |  | 0.9 | 1 |
| Total operating expenses | 19.8 | 19.8% | 21.0% |
| **Income from Operations** |  | **8.8%** | **7.8%** |

---

***Overall Gross Margin***

Overall gross margin as a percentage of revenue decreased marginally by 0.2% to 28.6% for the six months ended December 31, 2022, compared to 28.8% in the same period of Fiscal 2022. Gross profit increased by $888 to $6,957 for the six months ended December 31, 2022, from $6,069 for the same period of Fiscal 2022.

Gross profit margin as a percentage of revenue in the Manufacturing segment increased by 1.0% to 26.1% for the six months ended December 31, 2022, from 25.1% in the same period of Fiscal 2022. Gross profit increased by $473 to $2,255 for the six months ended December 31, 2021 compared to $1,782 for the same period of Fiscal 2022. The gross margin increase was primarily due to an increase in Manufacturing segment revenue in the first half of Fiscal 2023 compared to the same period of Fiscal 2022.

Gross profit margin as a percentage of revenue in the Testing segment decreased by 3.1% to 34.5% for the six months ended December 31, 2022, from 37.6% in the same period of Fiscal 2022. Gross profit in the Testing segment increased by $545 to $4,139 for the six months ended December 31, 2022, from $3,594 for the same period of Fiscal 2022 due to improved performance in the first quarter of Fiscal 2023. The decrease in gross profit margin was mainly due to lower margins in the Testing segment resulting from lower demand due to inventory corrections made by customers in the second quarter of Fiscal 2023.

Gross profit margin as a percentage of revenue in the Distribution segment was 16.0% for the six months ended December 31, 2022, compared to 16.1% in the same period of Fiscal 2022. Gross profit in the Distribution segment for the six months ended December 31, 2022, was $587, a decrease of $125 compared to $712 in the same period of Fiscal 2022. The decrease in gross profit was due to the decrease in distribution sales in our Singapore operation compared to the same period of Fiscal 2022.

Gross loss in the Real Estate segment increased by $5 for the six months ended December 31, 2022, from $19 in the same period of Fiscal 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -34-

------

***Operating Expense***

Operating expense for the six months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31,<br> 2022 | Dec. 31,<br> 2021 |
| (Unaudited) |  |  |
| General and administrative | $4224 | $3927 |
| Selling | 366 | 303 |
| Research and development | 224 | 213 |
| Gain on disposal of plant and equipment | 7 |  |
| **Total** | $4821 | $4443 |

---

General and administrative expense increased by $297, or 18.2%, from $3,927 to $4,224 for the six months ended December 31, 2022, compared to the same period of Fiscal 2022. The increase in general and administrative expense was primarily due to the general and administrative expense relating to the Company's new subsidiary Trio-Tech Jiangsu, which was setup in the third quarter of Fiscal 2022, coupled with increased manpower costs.

Selling expense increased by $63, or 20.8%, for the six months ended December 31, 2022, from $303 to $366 compared to the same period of Fiscal 2022. The increase in selling expense was primarily attributable to an increase in commission expense in the Manufacturing segment of Singapore operation as a result of an increase in commissionable revenue and increased travel costs.

***Income / (Loss) from Operations***

Income from operations was $2,136 for the six months ended December 31, 2022, compared to $1,626 for the same period of Fiscal 2022. The increase was mainly due to the increase in gross profit margin, offset by an increase in operating expense, as discussed earlier.

***Interest Expense***

Interest expense for the six months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31,<br> 2022 | Dec. 31,<br> 2021 |
| (Unaudited) |  |  |
| **Interest expense** | $54 | $56 |

---

Interest expense decreased marginally by $2 to $54 from $56 for the six months ended December 31, 2022, compared to the same period of Fiscal 2022. The decrease was mainly due to lower utilization of lines of credit in Singapore operation.

***Other (Expense) / Income***

Other (expense) / income for the six months ended December 31, 2022 and 2021 was as follows:

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31,<br> 2022 | Dec. 31,<br> 2021 |
| (Unaudited) |  |  |
| Interest income | $55 | $38 |
| Other rental income | 54 | 58 |
| Exchange loss | (279) | (4) |
| Bad debt recovery |  | 104 |
| Dividend Income |  |  |
| Government grant | 42 | 98 |
| Commission income |  | 200 |
| Other miscellaneous income | 64 | 48 |
| **Total** | $**(64)** | $**542** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -35-

------

Other expense for the six months ended December 31, 2022 was $64, a decrease of $606 compared to other income of $542 for the same period of Fiscal 2022. The decrease was mainly contributed by a negative foreign currency impact in the second quarter of Fiscal 2023 and the absence of one-time commission income that was earned in the same period in Fiscal 2022.

Our net income is impacted by the overall strengthening or weakening of the U.S. Dollar since the functional currency of our foreign subsidiaries is not the U.S. Dollar. During the second quarter in Fiscal 2023, exchange rate movement negatively impacted our net income due to the strengthening of Singapore dollars against the U.S. Dollar which was partially offset by the exchange gain that arose in the first quarter of Fiscal 2023.

***Income Tax Expense***

Income tax expense for the six months ended December 31, 2021 was $466, an increase of $133 compared to of $333 for the same period of Fiscal 2022. The increase in income tax expense was primarily due to increase in the taxable income across the Company in the six months ended December 31, 2022.

***Noncontrolling Interest***

As of December 31, 2022, we held a 55% interest in Trio-Tech (Malaysia) Sdn. Bhd., Trio-Tech (Kuala Lumpur) Sdn. Bhd., SHI International Pte. Ltd., and 52% interest in PT. SHI Indonesia. We also held a 76% interest in Prestal Enterprise Sdn. Bhd and 51% interest in Trio-Tech JiangSu Co. Ltd. The net income attributable to the noncontrolling interest in these subsidiaries for the six months ended December 31, 2022, was $154, a change of $142, compared to a net income of $12 for the same period of Fiscal 2022. The increase was attributable to the increase in net income generated by the China operation.

***Net Income Attributable to Trio-Tech International Common Shareholders***

Net income was $1,389 for the six months ended December 31, 2022, a decrease of $383 compared to a net income of $1,772 for the same period of Fiscal 2022. The increase was mainly due to the increase in revenue and gross margin. However, the increase was partially offset by an increase in operating expense and other expense.

***Earnings per Share***

Basic earnings per share from continuing operations was $0.34 for the six months ended December 31, 2022, compared to $0.46 for the same period in Fiscal 2022. Basic earnings per share from discontinued operations were $nil for both the six months ended December 31, 2022 and 2021.

Diluted earnings per share from continuing operations was $0.33 for the six months ended December 31, 2022, compared to $0.43 for the same period of Fiscal 2022. Diluted earnings per share from discontinued operations were $nil for both the six months ended December 31, 2022 and 2021.

**Segment Information**

The revenue, gross profit margin, and income or loss from operations in each segment for the six months ended December 31, 2022 and 2021, respectively, are presented below. As the segment revenue and gross margin for each segment have been discussed in the previous section, only the comparison of income / (loss) from operations is discussed below.

***Manufacturing Segment***

The revenue, gross margin and income from operations for the Manufacturing segment for the six months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31,<br> 2022 | Dec. 31,<br> 2021 |
| (Unaudited) |  |  |
| **Revenue** | $8629 | $7090 |
| **Gross margin** | 26.1% | 25.1% |
| **Income from operations** | $477 | $252 |

---

Income from operations from the Manufacturing segment was $477 for the six months ended December 31, 2022, an increase of $225 as compared to $252 in the same period of Fiscal 2022 due to an increase in gross margin. The increase in gross margin was partially offset with an increase in operating expense. The Manufacturing segment's operating expense were $1,778 and $1,529 for the six months ended December 31, 2022 and 2021, respectively. The increase in operating expense of $249 was mainly due to an increase in general and administrative expense by $75, and an increase in selling expense by $82 compared to the same period of Fiscal 2022. The increase in general and administrative expense was mainly attributable to an increase in payroll-related expenses in the Singapore operations. The increase in selling expense was primarily attributable to an increase in commission expenses in the Manufacturing segment of Singapore operation because of an increase in commissionable revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -36-

------

***Testing Segment***

The revenue, gross margin and loss from operations for the Testing segment for the six months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31,<br> 2022 | Dec. 31,<br> 2021 |
| (Unaudited) |  |  |
| **Revenue** | $12012 | $9566 |
| **Gross margin** | 34.5% | 37.6% |
| **Income from operations** | $1129 | $1124 |

---

Income from operations in the Testing segment for the six months ended December 31, 2022, was $1,129, a slight improvement of $5 compared to $1,124 in the same period of Fiscal 2022. The increase in gross profit of $545 was partially offset by an increase in operating expense by $540. Operating expense was $3,011 and $2,471 for the six months ended December 31, 2022 and 2021, respectively. The higher operating expense was mainly attributed to an increase in general and administrative expense and corporate overhead by $356 and $234, respectively.

The increase in general and administrative expense was mainly due to costs incurred in Company's new subsidiary Trio-Tech Jiangsu, which was setup in the third quarter of Fiscal 2022, coupled with increased manpower costs. The increase in corporate overhead expense was due to a change in the corporate overhead allocation compared to the same period of Fiscal 2022. Corporate charges are allocated on a predetermined fixed charge basis.

***Distribution Segment***

The revenue, gross margin and income from operations for the Distribution segment for the six months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31,<br> 2022 | Dec. 31,<br> 2021 |
| (Unaudited) |  |  |
| **Revenue** | $3676 | $4418 |
| **Gross margin** | 16.0% | 16.1% |
| **Income from operations** | $482 | $531 |

---

Income from operations in the Distribution segment for the six months ended December 31, 2022 was $482, a decrease of $49 compared to $531 in the same period of Fiscal 2022. The decrease in operating income was primarily due to a decrease in gross margin by $125, which was partially offset with a decrease in operating expense of $76. Operating expense were $106 and $180 for the six months ended December 31, 2022 and 2021, respectively. The decrease in operating expense was mainly contributed by decrease in general and administrative expense of $60.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -37-

------

***Real Estate Segment***

The revenue, gross loss margin and loss from operations for the Real Estate segment for the six months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31,<br> 2022 | Dec. 31,<br> 2021 |
| (Unaudited) |  |  |
| **Revenue** | $12 | $19 |
| **Gross loss margin**  | 200.0% | 100.0% |
| **Loss from operations** | $(42) | $(51) |

---

Loss from operations in the Real Estate segment for the six months ended December 31, 2022 was $42, a decrease of $9 compared to $51 for the same period of Fiscal 2022. The decrease in operating loss was mainly due to a decrease in operating expense. Operating expense was $18 and $32 for the six months ended December 31, 2022 and 2021, respectively.

***Corporate***

The income/(loss) from operations for corporate for the six months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
|  | Six Months Ended | Six Months Ended |
|  | Dec. 31,<br> 2022 | Dec. 31,<br> 2021 |
| (Unaudited) |  |  |
| **Income / (Loss) from operations** | $90 | $(230) |

---

The improvement of $320 was mainly due to a change in the corporate overhead allocation as compared to the same period last fiscal year. Corporate charges are allocated on a predetermined fixed charge basis.

**Financial Condition**

During the six months ended December 31, 2022 total assets increased by $2,775 to $46,196 compared to $43,421 as of June 30, 2022. The increase was primarily due to increase in inventories, trade receivables and property, plant and equipment and restricted term deposits, partially offset by decrease in cash and cash equivalents, short-term deposit, other receivables, prepaid expense, deferred tax assets, investment properties, right-of-use assets and operating right-of-use assets.

Cash and cash equivalents were $6,379 as at December 31, 2022, reflecting an decrease of $1,319 from $7,698 as at June 30, 2022, primarily due to placement of additional term deposits and repayment in lines of credit for the six months ended December 31, 2022.

Short-term deposits and restricted term deposits were $7,484 as at December 31, 2022, reflecting an increase of $386 from $7,098 as at June 30, 2022. The increase was primarily due to additional term deposits placement and also foreign currency movement.

As at December 31, 2022, the trade accounts receivable balance increased by $1,740 to $13,332, from $11,592 as at June 30, 2022, primarily due to an increase in overall revenue of all entities on a consolidated basis. The number of days' sales outstanding in accounts receivables for the Group was 91 days and 81 days at the end of the second quarter of Fiscal 2023 and the end of Fiscal 2022, respectively.

Other receivables as at December 31, 2022 mainly comprised of advance payments made to suppliers and refundable services taxes in the Singapore operations.

Inventories as at December 31, 2022, were $3,219, an increase of $961, compared to $2,258 as at June 30, 2022. The increase in inventories was in line with the backlog in the manufacturing and distribution segments of our Singapore operations.

Prepaid expenses were $610 as at December 31, 2022 compared to $1,215 as at June 30, 2022. This was mainly due to the asset capitalization of down payments made for the purchase of equipment in the China operation.

Investment properties' net in China was $533 as at December 31, 2022 and $585 as at June 30, 2022. The decrease was primarily due to the foreign currency exchange movement between June 30, 2022 and December 31, 2022.

Property, plant and equipment increased by $2,589 from $8,481 as at June 30, 2022, to $11,070 as at December 31, 2022, mainly due to the acquisition of new property, plant and equipment in the China operations. The increase was partially offset by the depreciation charged for the period and the foreign currency exchange movement between June 30, 2022 and December 31, 2022.

Other assets increased by $4 to $141 as at December 31, 2022 compared to $137 as at June 30, 2022. This was primarily due to the foreign currency exchange movement between June 30, 2022 and December 31, 2022.

Lines of credit was $nil as at December 31, 2022 as compared to $929 as at June 30, 2022. This was because of repayment of lines of credit in the Singapore Operation with no new utilization as of December 31, 2022.

Accounts payable increased by $666 to $3,067 as at December 31, 2022 as compared to $2,401 as at June 30, 2022 which was in line with the increase of sales and inventories.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -38-

------

Accrued expense increased by $803 to $6,807 as at December 31, 2022, as compared to $6,004 as at June 30, 2022. The increase in accrued expense was mainly due to an increase in accruals relating to acquisition pf property, plant and equipment in the China operations.

There was no significant change in bank loans payable as it decreased by $48 to $1,696 as at December 31, 2022, as compared to $1,744 as of June 30, 2022. This was due to the repayments made in the Malaysia operations.

Finance leases decreased by $67 to $170 as at December 31, 2022, as compared to $237 as at June 30, 2022. This was due to the repayments made in the Singapore and Malaysia operations.

Operating lease right-of-use assets and the corresponding lease liability decreased by $572 to $2,580 as at December 31, 2022, as compared to $3,152 as at June 30, 2022. This was due to the repayment made and the operating lease expenses charged for the period.

Other non-current liabilities increased by $1,144 to $1,172 as at December 31, 2022, as compared to $28 as at June 30, 2022. The increase was mainly due to an increase in accruals relating to acquisition of property, plant and equipment in the China operations where the payments term is more than 12 months.

**Liquidity Comparison** 

Net cash provided by operating activities increased by $2,942 to an inflow of $3,779 for the six months ended December 31, 2022, from an inflow of $837 for the same period of Fiscal 2022. The increase in net cash provided by operating activities was primarily due to an increase of $3,393 in cash inflow from changes in depreciation, other receivables, prepaid expense and other current assets and account payables and accrued expense in first half of Fiscal 2023 as compared to same period of Fiscal 2022. It was partially offset by an increase of $420 in cash outflow from changes in inventories and operating lease in first half of Fiscal 2023 as compared to same period of Fiscal 2022.

Net cash provided by investing activities decreased by $4,270 to an outflow of $3,428 for the six months ended December 31, 2022, from an inflow of $842 for the same period of Fiscal 2022. The increase in cash outflow was primarily due to an additions to property, plant and equipment of $3,994.

Net cash outflow from financing activities for the six months ended December 31, 2022, was $1,032, representing a decrease of $1,105, as compared to cash inflow of $73 during the six months ended December 31, 2021. The decrease was mainly attributable to a higher payment on lines of credit by $856.

On March 1, 2022, the Company's Registration Statement on Form S-3 (File No. 333-261485) was declared effective by the SEC, pursuant to which we may raise capital of $10,000,000 USD of any combination of securities (common stock, warrants, debt securities or units) for expansion of the Company's testing capacity and working capital purposes if necessary.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Not applicable.

**ITEM 4. CONTROLS AND PROCEDURES**

An evaluation was carried out by the Company's Chief Executive Officer and Chief Financial Officer of the effectiveness of the Company's disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of December 31, 2022, the end of the period covered by this Form 10-Q. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective at a reasonable level.

**Changes in Internal Control Over Financial Reporting** 

There has been no change in the Company's internal control over financial reporting during the fiscal quarter ended December 31, 2022, that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -39-

------

**TRIO-TECH INTERNATIONAL**

**<u>PART II. OTHER INFORMATION</u>**

**ITEM 1. LEGAL PROCEEDINGS**

Not applicable.

**ITEM 1A. RISK FACTORS**

Not applicable.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

Not applicable.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

Not applicable.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

**ITEM 5. OTHER INFORMATION**

Not applicable.

**ITEM 6. EXHIBITS**

---

| | |
|:---|:---|
| [31.1](ex_470787.htm) | Rule 13a-14(a) Certification of Principal Executive Officer of Registrant |
| [31.2](ex_470788.htm) | Rule 13a-14(a) Certification of Principal Financial Officer of Registrant  |
| [32](ex_470789.htm) | Section 1350 Certification |
| 101.INS | Inline XBRL Instance Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -40-

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| **TRIO-TECH INTERNATIONAL** | **TRIO-TECH INTERNATIONAL** |
| By: | <u>/s/ Srinivasan Anitha</u><br>SRINIVASAN ANITHA<br> Chief Financial Officer<br> (Principal Financial Officer)<br> Dated: February 10, 2023 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -41-

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATIONS**

I, S. W. Yong, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Trio-Tech International, a California corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: February 10, 2023

<u>/s/ S. W. Yong</u>

S. W. Yong, Chief Executive Officer

and President (Principal Executive Officer)

## Exhibit 31.2

**Exhibit 31.2**

I, <u>Srinivasan Anitha</u>, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Trio-Tech International, a California corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: February 10, 2023

<u>/s/ Srinivasan Anitha</u>

<u>Srinivasan Anitha</u> , Chief Financial Officer (Principal Financial Officer)

## Ex-32

**Exhibit 32**

SECTION 1350 CERTIFICATION

Each of the undersigned, S.W. Yong, President and Chief Executive Officer of Trio-Tech International, a California corporation (the "Company"), and Srinivasan Anitha, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his or her knowledge (1) the quarterly report on Form 10-Q of the Company for the three months ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

<u>/s/ S. W. Yong</u>

Name: S. W. Yong

Title: President and Chief Executive Officer

Dated: February 10, 2023

<u>/s/</u><u> </u><u>Srinivasan Anitha</u>

Name: <u>Srinivasan Anitha</u>

Title: Chief Financial Officer

Dated: February 10, 2023

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.